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Many Proteobacteria use a cell-cell communication system called quorum sensing (QS) 
to coordinate gene expression in a cell density-dependent manner. Cell density is detected 
through the production and diffusion of acyl-homoserine lactones (AHLs). The AHL 
concentration increases until threshold is reached, and AHLs bind the AHL receptor causing 
transcription of QS-controlled genes. Many QS-controlled genes include: antimicrobials, biofilm 
components, and other virulence factors. For this reason, we believe that QS is critical for 
survival during competition with other bacteria. To test our hypothesis, we have developed a 
competition model between two soil-saprophytes, Burkholderia thailandensis and 
Chromobacterium violaceum.  
Our research demonstrates that QS in C. violaceum and B. thailandensis controls the 
production of antimicrobials that inhibit the other species’ growth. C. violaceum using QS to 
increase resistance to bactobolin, a B. thailandensis antibiotic, through a RND efflux pump. This 
QS-controlled efflux pump is important for limiting QS-deficient mutants in our competition 
model allowing for the increase in antimicrobial producing cells and increased survival of C. 
violaceum during competition. Our results demonstrate that interspecies competition can 
reinforce QS-controlled behaviors by placing constraints on QS-deficient mutants. 
Additionally, we demonstrate that the AHL receptor, CviR, in C. violaceum Cv017 can 
bind to N-octanoyl-L-homoserine lactone (C8-HSL) and N-3-hydroxyoctanoyl-L- (3OH-C8)-
HSL produced by B. thailandensis. RNA sequencing of transcripts from C. violaceum grown in 
the presence of C8-HSL or hexanoyl (C6)-HSL revealed an enrichment in the transcriptome for 
competition associated genes when exposed to C8-HSL. Our transcriptomic and competition 
results show that the ability of C. violaceum to detect non-cognate AHLs provides an advantage 
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Bacteria exist in mixed microbial communities and interact with diverse species of 
bacteria, fungi, yeast, and protozoa. Despite bacteria existing in these mixed communities, most 
research focuses on bacteria in isolated cultures leading to the question of how bacteria interact 
with other species. There are many examples of cooperation between species such as the dental 
species: Aggregatibacter actinomycetemcomitans, Fusobacterium nucleatum, and Veillonella 
species which cooperate to form biofilms on teeth [1]. However, research by Dr. Kevin Foster 
and Dr. Thomas Bell looked at the ability of 180 two-species mixtures to cooperate by measuring 
overall respiration [2]. They concluded that the majority of interactions between species was 
competitive and not cooperative. 
In diverse environments, it is often beneficial for bacteria to function as a cooperating 
population instead of as an individual in order to thrive. Therefore, it is not surprising that many 
bacterial species have developed chemical signals to coordinate gene expression within a 
population. Many Gram-negative bacteria coordinate gene expression through a cell-density 
dependent communication system called quorum sensing (QS). Gene activation occurs when a 
“quorum” is reached, thus such systems are referred to as “quorum sensing” systems [3]. Gram-
positive bacteria have a similar system for coordinating gene expression called pheromone 
signaling. While most Gram-negative bacteria have a QS system, the best-characterized QS 
systems can be found in Proteobacteria. The size of the QS regulon varies widely but most 
Proteobacteria have QS-controlled antimicrobials. Recently we and others have characterized 
QS-controlled antimicrobial resistance through efflux pumps [4]. We are interested in 
determining how interspecies bacterial competition may have influenced the collection of genes 
that are regulated by QS. 
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In the following sections, we will review 1) the discovery and molecular mechanism of 
Proteobacterial QS systems, 2) the importance of QS in the soil bacteria Chromobacterium 
violaceum, 3) a dual-species competition model, and 4) RND-mediated antibiotic resistance in 
Proteobacteria. 
Quorum sensing in Proteobacteria 
The first QS system was characterized in 1979 in the bioluminescent marine bacterium, 
Vibrio fisheri [5]. V. fisheri colonizes the light organ of the Hawaiian squid, Euprymna scolopes, 
forming a symbiosis where V. fisheri acquires nutrients and produces light that helps camouflage 
the squid at night. V. fisheri is only able to reach a high cell density, or quorum, inside the 
nutrient rich environment of the light organ. Light production occurs through the expression of 
the luciferase operon (LuxCDABEG) [6]. Activation of the luciferase operon was found to be 
dependent on two regulatory genes, luxI, which encodes the signal synthase, and luxR, which 
encodes the signal receptor and transcriptional regulator [3]. LuxI signal synthase produces the 
signal molecule N-3-oxohexanoyl-homoserine lactone (3-oxo-C6-HSL). A “quorum” is reached 
when 3-oxo-C6-HSL accumulates inside the cell and binds LuxR activating about thirty genes, 
including the luciferase operon and luxI [7-9]. The positive regulation of luxI causes a rapid and 
significant increase in signal production ensuring uniform activation of QS genes in the 
population (Figure 1). 
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Figure 1. Mechanism of quorum sensing  
LuxI-signal synthase constantly produces a low 
level of AHL signals that diffuse out of the cell. 
LuxR-signal receptor is degraded when not 
bound to its specific signal. Once the AHL 
reaches a critical concentration, the signal binds 
LuxR and forms a homodimer with another 
LuxR-AHL complex. The LuxR-AHL 
homodimer activates transcription of select 
genes, including luxI, creating a positive 
feedback loop that drastically increases the 
signal concentration. 
 
LuxI homologs produce acyl-homoserine lactones (AHLs) as the signal molecule. 
Biosynthesis of the AHL signal generally requires the central metabolite S-adenoslmethionine 
(SAM) for the homoserine lactone ring and the acyl side chain from fatty acid biosynthesis [10-
12]. Variation in the acyl side chain provides specificity to the individual QS systems. Acyl side 
chains are usually straight but can be derived from aromatic acids [13, 14]. Additionally, the acyl 
side chain can vary in length from 4 to 18 carbons, have varying degrees of saturation, and can 
have substitutions on the third carbon. This variation provides specificity to the QS system. 
The AHL binds with the N-terminal of LuxR homologs at a structurally conserved AHL-
binding domain [13, 14]. Without a signal, LuxR homologs are inactive and quickly degraded. 
Upon binding the AHL, LuxR undergoes a conformational change allowing it to bind to another 
LuxR-AHL complex to form a homodimer [15]. This homodimer then functions as a 
transcription factor and binds DNA at the C-terminal helix-turn-helix domain. LuxR-family 
proteins typically bind a DNA sequence called the lux box generally found upstream of the target 
gene [16]. The lux box is usually 14-18bp long and is a palindrome sequence following the 
pattern CTGNNCCNNGGNNGAC. LuxR responsive genes can be anywhere in the genome, but 
luxR and luxI are usually adjacent on the chromosome. LuxR-family transcriptional regulators 





normally activate expression of target genes, but in a few cases, LuxR-family proteins repress 
gene transcription [17-19].  
Most QS-controlled genes fall into several general groups: toxins (e.g., antimicrobials), 
exoenzymes (e.g., proteases), biofilm components, and cellular proteins (e.g., metabolism). 
Many of these genes encode products that are important for group behaviors that are costly to the 
individual cell but are beneficial at high cell density. For example, the production of biofilm 
proteins, proteases, or antimicrobials are less effective at low concentration and a waste of 
energy that is better spent on growth. Thus, QS may serve as a cost-saving strategy for 
metabolically expensive products that are not useful at low density [20, 21]. Additionally, it is 
believed that QS delays production of antimicrobials until a lethal concentration can be delivered 
to prevent the adaptation of competitors to a sub-inhibitory concentration [22, 23]. In this 
dissertation we evaluate the effect of group behaviors and competition as evolutionary forces that 
shaped the QS regulon in Chromobacterium violaceum. 
Chromobacterium violaceum 
Overview of the Chromobacterium genus 
 In 1880 Italian scientist Bergonzini from Modena University found that his cultures were 
contaminated by a “fantastic” film of violet color [24]. He initially suspected Cromococcus 
violaceus, the only known bacteria to have purple coloration. However, further testing revealed 
this contamination to be a novel bacterium Bergonzini termed, Cromobacterium (sic) violaceum 
and published his findings in 1881. The only earlier report of a similar species was the 
publication of a communication by Gessard in 1867 [25]. In this publication, Gessard describes a 
“small organism” causing violet coloration on rice. In 1882, Boisbaudran, a contemporary of 
Gessard, published an article in Compt Rendues d’ Academie du Science where he named the 
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“small organism” Chromobacterium violaceum and characterized the purple pigment, violacein, 
using visible absorption spectra. The spelling of Cromobacterium (sic) by Bergonzini was 
corrected later that same year cementing the nomenclature of Chromobacterium violaceum. 
 Chromobacterium violaceum is currently defined as a Gram-negative, facultative 
anaerobe of the β-Proteobacteria family and is found in water and soil samples of the tropics and 
subtropics around the world. Although C. violaceum is the most recognized species of the 
Chromobacterium genus, currently there are 11 species: C. violaceum, C. subtsugae, C. 
haemolyticum, C aquaticum, C. piscinae, C. amazonense, C. pseudoviolaceum, C. alkanivorans, 
C. vaccinii, C. sphagni, and C. rhizoryzae. All species are rod-shaped, motile with a single 
flagellum, and most species are able to ferment glucose and reduce nitrate. The most 
recognizable feature is the purple pigment, violacein, though it is no longer a defining feature of 
all species. There are four non-pigmented species: C. aquaticum, C. haemolyticum, C. 
alanivorans, and C. rhizoryzae. Since most species are nonpathogenic, there has been minimal 
research in this genus. The unique characteristics of each species are discussed in Chapter II. 
Violacein is a bisindole (see structure in Figure 2) 
formed by the condensation of two tryptophan through 
the action of five proteins encoded by vioABCDE [26]. 
There are several bacteria genera, including: Collimonas, 
Duganella, Janthinobacterium, Microbulbifer sp., and Pseduoalteromonas, that produce 
violacein, but C. violaceum is the best-known species for violacein production [27]. Violacein is 
a broad-spectrum antimicrobial, an antifungal, and is believed to protect Chromobacterium from 
eukaryotic predators, such as C. elegans [28-30]. Another study demonstrated the ability of 
Figure 2. Structure of violacein 
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violacein to provide protection from ultra-violet light damage [25]. Violacein has also been 
shown to have antimalarial properties [31].  
Clinical reports of Chromobacterium infections 
 Most members of the Chromobacterium genus are nonpathogenic, but infections of C. 
violaceum and C. haemolyticum in humans and mammals have been reported [32, 33]. Infections 
commonly present with fever, abdominal pain, skin abscesses, sepsis, leukocytosis, and liver 
abscesses. The first infection of C. violaceum was documented in the 1930s and there have been 
over 150 documented cases to date [34]. However, 65% of those cases were reported after 1990. 
Whether this increase in prevalence is due to better access to healthcare, improved 
documentation, or due to increased pathogenicity remains to be seen. Infections of C. violaceum 
are reported every year and mortality rates range from 7% in the United States and Australia to 
53% in Southeast Asia [34]. In 2017 there were 23 new cases of human infection with a 
mortality rate of 35% (8 deaths) [35]. The decrease in fatality rate may be attributed to improved 
diagnostic and treatment regimes. Antimicrobial susceptibility information for clinical specimens 
is limited and extremely variable. However, C. violaceum is known to be resistant to β-lactams 
and has become resistant to ticarcillin, carbenicillin, and cefoxitin [34]. The current antibiotic 
regiment usually involves a treatment with a fluoroquinolone, carbapenem, or ciprofloxacin for 
2-3 weeks followed by 3-6 months of treatment with trimethoprim sulfamethoxazole, 
tetracycline, or fluoroquinolone to prevent relapse.  
C. haemolyticum was first isolated from human sputum and demonstrated remarkable 
hemolytic activity in human and sheep erythrocytes [33]. Infections by C. haemolyticum are even 
more rare than C. violaceum infections and have not been associated with any mortalities. 
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Interestingly, C. haemolyticum isolated from tropical freshwater also exhibited strong β-
hemolytic activity and high resistance to β-lactams as seen in the clinical isolate [36]. 
 Until recently, there was no research into the molecular mechanisms of 
Chromobacterium virulence. C. violaceum ATCC 12472 has two pathogenicity islands: Cpi-1 
and Cpi-2, which resemble the pathogenicity islands Spi-1 and Spi-2 in Salmonella [37]. 
Phylogeny studies revealed that Cpi-1 can be found in most species of Chromobacterium and 
deletion of this pathogenicity island resulted in a remarkable decrease in virulence in a mouse 
model [35, 37]. Interestingly, the genes encoding the needle complex (Cpi-1a) were located 
distantly from the Cpi-1 cluster and appear to be important for infection. More research is needed 
to identify the function of the at least 16 effector proteins associated with Cpi-1/1a. More 
research is also needed to determine the role of Cpi-2 in infection. In Salmonella, Spi-2 is 
important for survival in macrophages [38]. 
 In the mouse model, C. violaceum is detected by macrophages through recognition of the 
Cpi-1a T3SS needle protein CprI [37]. Detection of CprI causes up-regulation of the 
inflammasome through Nod-like receptor (CARD domain-containing protein 4 (NLRC4)). The 
inflammasome eliminates C. violaceum through pyroptosis and natural killer (NK) cell 
cytotoxicity which eject the bacteria from macrophages and hepatocytes. The bacteria are then 
vulnerable to killing by neutrophils [39]. This mode of clearing the infection corresponds with 
what is known about human infections of C. violaceum. A comorbidity with chronic 
granulomatous disease, an autoimmune disease characterized by difficulty making reactive 
oxygen compounds, is often reported but is not found in all cases [34, 40]. C. violaceum is 
classified as a BSL-2 bioagent and potential emerging pathogen due to the ability of C. 
violaceum to infect humans and multiple non-primate mammals [41, 42]. 
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Overview of Chromobacterium violaceum strain CV017 
 Most of what is known about C. violaceum comes from studies in the reference strain C. 
violaceum ATCC 12472 as this is the only complete genome [43]. However, another commonly 
used strain is C. violaceum ATCC 31532 which was isolated prior to 1982 from the New Jersey 
Pine Barrens [44]. Little is known about strain ATCC 31532 other than basic growth conditions 
and that it produces a monobactam. Compared to the reference strain C. violaceum ATCC 
12472, strain ATCC 31532 has decreased violacein production. To increase violacein levels, a 
transposon was inserted into a previously unknown site (discussed in Chapter II) and this strain 
was named C. violaceum strain CV017. Research in this dissertation is conducted with C. 
violaceum strain CV017.  
One of the best characterized features of C. violaceum strains, including CV017, are their 
ability to detect AHLs from other species. The LuxR homolog, CviR, can bind AHLs with 
saturated acyl-side chains that range from 4-12 carbons in length [45]. This feature has made C. 
violaceum a common biosensor for detecting AHLs. As a biosensor, the native AHL synthase, 
cviI, is disrupted through deletion or transposon insertion making the strain light yellow in 
appearance. When grown near other bacteria producing AHLs or if exogenous AHLs are added 
to the media, then C. violaceum will turn purple through the QS-controlled production of 
violacein. Indeed, violacein is so responsive to AHL concentration, that standard curves can be 
created to determine the quantity of AHLs in the media [45, 46].  
 In addition to regulating violacein, QS in C. violaceum strains has been shown to activate 
transcription of exoproteases, hydrogen cyanide, antibiotics (aerocyanidin, aerocavin, 3,6-
Dihydroxy-indoxazene, and monobactam SB_26.180), β-lactamase, antitumoral depsipeptide 
(histone deacetylase), and type III secretion system proteins [25, 47, 48]. Many of the genes 
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responsible for these phenotypes remain unknown but are important for competition providing 
motivation for determining the QS regulon by RNA-sequencing in Chapter IV. 
In addition to the QS regulon being unknown, the genome of strain CV017 was not 
sequenced prior to this dissertation (see Chapter II). At that time the only fully sequenced 
genome for C. violaceum is strain ATCC12472. Since 2015 there has been a drastic increase in 
the number of draft genomes for the broader Chromobacterium genus. Using phylogenetic 
analysis of these genomes, we demonstrate in Chapter II that C. violaceum CV017 is a member 
of the C. subtsugae species. For the sake of clarity, we will refer to C. violaceum CV017 as 
Chromobacterium sp. CV017 after Chapter II.  
Dual-species competition model 
While most QS systems control antibiotic production, there are very few studies 
evaluating the importance of QS during interspecies competition. The dual-species model 
between C. violaceum and Burkholderia thailandensis used in this dissertation was originally 
developed by Dr. Josephine Chandler [23]. These two bacteria were chosen for their similar 
laboratory growth conditions, defined QS systems, and QS-controlled antimicrobials. 
B. thailandensis is also a β-Proteobacteria and soil saprophyte. While C. violaceum has a 
single QS system, B. thailandensis has three LuxI-LuxR pairs: BtaI-BtaR 1, BtaI-BtaR 2, and 
BtaI-BtaR 3 which respond to N-octanoyl-L-homoserine lactone (C8-HSL); N-3-
hydroxyoctanoyl-L-HSL (3OH-C8-HSL) and N-3-hydroxydecanol-L-HSL (3OH-C10-HSL); and 
3OH-C10-HSL, respectively. These QS circuits are also conserved in the human pathogens 
Burkholderia mallei and Burkholderia pseudomallei. Since B. thailandensis is nonpathogenic, it 
is a convenient model for studying QS and other conserved pathways for the pathogenic species. 
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B. thailandensis has at least 12 polyketide 
synthase (PKS) or non-ribosomal peptide synthase 
(NRPS) clusters [49]. The bta PKS/NRPS hybrid 
cluster is controlled by the BtaIR 2 QS circuit. This 
cluster produces the antibiotic bactobolin which is a 
broad-spectrum antibiotic. There are 8 classes (A-H) 
of bactobolins (Figure 3) with bactobolin A and 
bactobolin C being the most potent [50, 51]. 
Bactobolin is believed to disrupt ribosome activity as 
evolved-resistance to bactobolin in Bacillus subtilis occurs through the L2 protein in the 50S 
subunit [51]. L2 is required for association between the 50S and 30S subunits and full activity of 
the peptidyl-transferase center. B) Structure of each class (A-H) of bactobolin adapted from [51]. 
Based on the location of bactobolin-resistant mutations in B. subtilis, bactobolin is believed to 
inhibit peptidyl transfer. There is a homolog of L2, L8e, in the eukaryotic ribosome which may 
explain why bactobolin A and bactobolin C are also toxic to murine fibroblasts. 
In competition experiments between wildtype B. thailandensis and wildtype C. violaceum 
(described in Chapter III), Burkholderia is able to increase in frequency indicating that it is able 
to “win” the competition (Figure 4). The ability of B. thailandensis to inhibit C. violaceum is 
dependent on QS. The deletion of signal synthases in B. thailandensis allows C. violaceum to 
increase in frequency, and the addition of B. thailandensis AHLs to the competition restores B. 
thailandensis to victory. Deletion of bactobolin mirrored the effect of deleting the signal 
synthases in B. thailandensis indicating that bactobolin is the QS-controlled antimicrobial that is 
responsible for inhibiting C. violaceum (Figure 4) [23, 49].  
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C. violaceum also has a QS-controlled antimicrobial factor that inhibits the growth of B. 
thailandensis, but the specific antimicrobial factor is unknown [23]. Additionally, the ability of 
C. violaceum to detect AHLs produced by B. thailandensis increases C. violaceum survival under 
certain conditions (Figure 4). Research in Chapter IV investigates which AHL from B. 
thailandensis is most important for increasing survival of C. violaceum and which genes respond 
to noncognate AHLs. 
Figure 4. QS-controlled bactobolin produced by B. 
thailandensis inhibits C. violaceum during 
competition 
A) Adapted from [23]. Co-culture competition of wild-
type C. violaceum (Cv) and wild-type or mutant strains of 
B. thailandensis (Bt) indicated on the x-axis. The dashed 
line indicates the starting 10:1 ratio of Bt:Cv which offsets 
the slower growth of Bt. The ratio of Bt:Cv was 
determined after 24h by selective plating and colony 
counts. AHLs were extracted from Bt supernatant. 
Deletion of bactobolin (Δbactobolin) prevents killing of 
Cv demonstrating the importance of bactobolin during competition. Error bars represent the 
standard error of the mean.  
 
RND efflux pumps 
Upon starting my dissertation research, I demonstrated that QS in C. violaceum also 
controls an antibiotic resistance factor that increases survival during competition. Further 
experimentation discussed in Chapter III led to the conclusion that this resistance factor was an 
efflux pump. Sequencing revealed that this efflux pump most closely matched the AcrAB 
proteins from Escherichia coli and Mex pumps in Pseudomonas aeruginosa. Both pumps are 
part of the RND (resistance-nodulation division) superfamily. Importantly, at that time, very few 
QS-controlled efflux pumps had been identified to provide antibiotic resistance.  
Efflux pumps are classified by phylogenetic similarities in structure. There are five major 
classes of efflux pumps: RND, MFS (major facilitator superfamily), MATE (multidrug and toxic 
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compound extrusion), SMR (small multidrug resistance), and ABC (ATP-binding cassette) 
transporters [52]. All families except ABC transporters use proton motive force to efflux their 
substrates while ABC transporters use ATP hydrolysis to drive exportation. 
The most detailed information on RND efflux pumps comes from studies on AcrAB-
TolC in E. coli. All RND efflux pumps consist of three proteins: an ATPase inner membrane 
pump (AcrB), a periplasmic adaptor(AcrA), and an outer membrane porin (TolC) [53]. In E. coli, 
acrAB are linked in the chromosome while tolC is located elsewhere. However, in most other 
systems all three genes are linked in the chromosome. RND systems can also be found on 
plasmids. Some of the efflux pumps in the MATE and ABC transporter superfamilies are also 
organized into tripartite complexes, but SMR and MFS superfamilies are single protein 
transporters located in the inner membrane [52]. Since RND and other tripartite efflux pumps 
can export directly into the extracellular environment, they contribute more to antibiotic 
resistance than SMR or MFS efflux pumps which excrete into the periplasmic region. By 
exporting into the extracellular environment, the effectiveness of RND efflux pumps is directly 
related to the ability of the compound to cross the outer membrane. In fact, permeabilizing the 
outer membrane has nearly the same effect as deleting the efflux pump [54]. Most RND efflux 
pumps have very wide specificity which may include antibiotics, detergents, dyes, free fatty 
acids, and quorum sensing molecules [52]. Not surprisingly most of these compounds have at 
least one hydrophobic domain making facilitated diffusion required. The specificity of each 
efflux pump seems to be linked to the size of the pore created by AcrB in the inner membrane.  
RND efflux pumps are regulated by local and global transcription factors. Most RND 
efflux pumps are repressed at the local level by a divergently transcribed TetR repressor family 
protein [55]. TetR family proteins have a C-terminal ligand binding domain and a N-terminal 
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DNA-binding domain [56]. In the absence of antibiotics, TetR family proteins repress the RND 
efflux pump [57]. However, this repression is not tight allowing for constitutive expression of the 
efflux pump. In the AcrAB-TolC efflux pump in E. coli, the QS-regulator, SdiA, increases 
transcription of the AcrAB operon 2- to 3-fold [4].  
Allocation of work 
 In Chapter 2, the genome sequencing was published in Genome Announcements 
(10.1128/genomeA.00080-16) [58]. The DNA libraries were created by the University of Kansas 
(KU) Genome Sequencing Core and the genome assembly and annotation were done by Dr. 
Stuart Macdonald and Xiaofei Wang. The DNA libraries were sequenced by the Kansas State 
University Integrated Genomics Facility. The 16S RNA phylogenetic analysis and comparison of 
Chromobacterium species is unpublished and completed by Kara Evans. 
 All of Chapter 3 was published in the International Society of Microbial Ecology 
(10.1038/s41396-018-0047-7) [59]. The cdeAB-oprM deletion mutants were created by Saida 
Benomar. Genome sequencing of the bactobolin-resistant, quorum sensing-deficient C. 
violaceum was done by the KU Genome Sequencing Core. The purified bactobolin A used in the 
casein evolution experiments was purified from B. thailandensis supernatant through HPLC by 
Ben Neuenswander. The casein evolution experiments with bactobolin A were conducted by 
Lennel Camuy-Velez. Ellen B Nasseri assisted Kara Evans with all other casein evolution 
experiments. All other experiments were conducted by Kara Evans. 
 The work in Chapter 4 is unpublished. To determine the amount of acyl-homoserine 
lactones produced by C. violaceum, Kara Evans completed all sample prep and Todd Williams, 
Director of the Mass Spectrometry Laboratory and Analytical Proteomics Laboratory at the 
University of Kansas, ran the time of flight-MS/MS and helped with analysis of the results. Kara 
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Evans conducted all the competition experiments to determine which AHL produced by B. 
thailandensis was detected by C. violaceum. For the RNA sequencing, Kara Evans prepared all 
the RNA samples while the libraries were generated by the KU Genome Sequencing Core. The 
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Reassessment of the taxonomic position of Chromobacterium violaceum CV017 and a 




The genome of Chromobacterium violaceum CV017 was sequenced “de novo” and compared to 
the genome of C. violaceum ATCC 12472. The genome-wide comparison yielded only a 64.4% 
similarity to C. violaceum ATCC 12472 but 98% similarity to C. subtsugae. The genome of C. 
subtsugae has fewer nitrate reductases, a unique biosynthetic complex encoding secondary 
metabolites, and lacks the second pathogenicity island, Cpi-2. C. violaceum CV017 has these 
same features and also has the same quorum sensing signal, N-hexanoyl-homoserine lactone, as 
C. subtsugae leading to the conclusion that C. violaceum CV017 has been improperly classified. 
Further phylogenetic analysis using 16S RNA of all 45 sequenced genomes of Chromobacterium 





The soil saprophyte Chromobacterium violaceum is an occasional human pathogen 
known for its ability to produce a purple pigment, violacein [1]. The strain CV017, derived from 
a soil isolate (ATCC 31532), has a transposon insertion at an unknown site causing 
overproduction of violacein [2, 3]. Violacein is controlled by acyl-homoserine lactone-dependent 
quorum sensing, and derivatives of CV017 have been widely utilized as acyl-homoserine lactone 
biosensors [4]. CV017 is also useful to understand the role of quorum sensing in interspecies 
competition because of its growth characteristics and quorum-dependent antimicrobials. When 
we sequenced our genome in 2015, only one other C. violaceum strain had been sequenced, 
ATCC 12472 (accession NC_005085.1)[5]. To date, 17 genomes of Chromobacterium 
violaceum have been sequenced and are available on the National Center for Biotechnology 
Information (NCBI) website. Here we report the draft genome sequence of the genetically 
distinct strain CV017.  
Publications on the broader genus of Chromobacterium have drastically increased in the 
last decade with research primarily focusing on C. violaceum and C. haemolyticum infections, 
medical and agricultural applications of secondary metabolites, and identification of novel 
species from soil isolates [6]. Importantly, this research has included the sequencing of numerous 
Chromobacterium strains and lead to the creation of 11 species of Chromobacterium (see Table 
2). The rapid expansion of sequenced Chromobacterium species genomes allowed us to 
investigate the phylogenetic relationship of CV017 to all species of Chromobacterium. There are 
45 draft or complete genomes of the genus Chromobacterium found in NCBI, and we used 16S 
RNA sequences to evaluate the relationship of each strain. We discovered that C. violaceum 
CV017 shares more sequence similarity with C. subtsugae than other strains of C. violaceum and 
clusters with other members of C. subtsugae based on 16S RNA. This homology and other 
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metabolic characteristics lead us to conclude that C. violaceum CV017 is a member of the C. 
subtsugae.  
Materials and Methods 
Genome sequencing and annotation 
CV017 cells were grown in Luria-Bertani media, and genomic DNA was isolated using 
the Gentra Puregene Bacteria/Yeast kit (Qiagen). The DNA was used to make a sequencing 
library with 1-kb inserts and was sequenced on an Illumina MiSeq generating 300-bp paired-end 
reads. Raw reads were preprocessed with Scythe v0.991(https://github.com/vsbuffalo/scythe) 
and Sickle v1.200 (https://github.com/najoshi/sickle) to improve read quality, aligned to the 
phiX174 genome via Bowtie2 v2.1.0 to remove any contaminating reads, and assembled with 
ABySS v1.9.0 using an empirically determined optimal k-mer size of 115 [7, 8]. We annotated 
the assembly using NCBI Prokaryotic Genomes Annotation Pipeline (PGAP) 
(http://www.ncbi.nlm.nih.gov/genome/annotation_prok/). 
Dendrogram construction 
 The phylogenetic tree is based on the 16S rRNA gene of Chromobacterium violaceum 
strain CV017 (GenBank accession no. LKIW01000119.1). The number of species was limited to 
the 45 strains that had genome assembly information available in NCBI. The accession number 
of each gene can be found in Table 1. The phylogenetic tree was constructed based on neighbor-
joining and supported by maximum-likelihood and maximum-parsimony algorithms [9]. All 






Table 1. GenBank accession number for 16S RNA sequence 
Species name Accession Number 
Chromobacterium vaccinii strain XC0014  MF186165.1  
Chromobacterium sp. ATCC 53434  CP025429.1 
Chromobacterium vaccinii strain 21-1 CP017707.1 
Chromobacterium vaccinii strain MWU328   JN120870.1  
Chromobacterium vaccinii strain MWU205 NR_109451.1 
Chromobacterium sp. MWU2920 KJ576863.1  
Chromobacterium sp. MWU2387  KJ576860.1 
Chromobacterium sp. MWU3525 KJ576868.1  
Chromobacterium violaceum strain CV1197  CP024029.1 
Chromobacterium violaceum strain CV1192  CP024028.1 
Chromobacterium sp. MWU2576 KJ576867.1  
Chromobacterium violaceum ATCC 12472 AE016825.1 
Chromobacterium piscinae strain LMG 3947  NR_114953.1  
Chromobacterium sp. strain 56AF  MG041385.1  
Chromobacterium rhizoryzae strain LAM1188 NR_152068.1  
Chromobacterium alkanivorans strain IITR-71  NR_153735.1  
Chromobacterium haemolyticum strain H5244 MUKV01000078.1 
Chromobacterium haemolyticum strain H3973 MUKT01000095.1 
Chromobacterium haemolyticum strain T124 JRFR01000058.1  
Chromobacterium sp. LK11  LDUR01000038.1  
Chromobacterium violaceum strain ATCC 315322 PKBZ01000001.1  
Chromobacterium sp. F49 LQNP01000027.1  
Chromobacterium violaceum strain CV017 LKIW01000119.1 
Chromobacterium subtsugae strain PRAA4-1  JYKA01000038.1  
Chromobacterium subtsugae strain F49 JWJN01000034.1  
Chromobacterium piscinae strain ND17 JTGE01000086.1  
Chromobacterium sp. MWU14-2602  PQWB01000082.1  
Chromobacterium violaceum strain GHPS1 NHOO01000041.1  
Chromobacterium violaceum strain H5525 MUKX01000058.1 
Chromobacterium violaceum strain H5524 MUKW01000048.1  
Chromobacterium violaceum strain 16-419B MUKR01000045.1  
Chromobacterium violaceum strain 16-419A MUKQ01000045.1  
Chromobacterium violaceum strain GN5 JWPW01000031.1  
Chromobacterium violaceum strain 16-454 MUKS01000046.1  
Chromobacterium violaceum strain LK30  LDUX01000035.1  
Chromobacterium violaceum strain LK17  LDUU01000022.1  
Chromobacterium sp. LK1 LDUI01000072.1  
Chromobacterium subtsugae strain MWU12-2387 MQZZ01000079.1 
Chromobacterium pseudoviolaceum strain LMG 3953 MQZX01000025.1  
Chromobacterium violaceum strain LK15 LDUT01000054.1  
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Chromobacterium violaceum strain LK6 LDUM01000020.1  
Chromobacterium haemolyticum strain H4137 MUKU01000082.1 
Chromobacterium violaceum strain L1B51 JYGI01000011.1 
Chromobacterium sphagni strain IIBBL 14B-1 MKCT01000094.1  
Chromobacterium sphagni strain IIBBL 37-2 MKCS01000001.1 
 
Results 
The resulting assembly of C. violaceum CV017 contigs consists of 211 scaffolds with an 
N50 scaffold size of 40,489-bp [10]. The total length of the chromosome is 4,774,638-bp and 
read coverage of the scaffolds is around 1,250×. The G+C content of the sequence is 64.5%. The 
assembly was annotated using NCBI PGAP 
(http://www.ncbi.nlm.nih.gov/genome/annotation_prok/), identifying 4,178 potential CDS 
(coding DNA sequences) on 168/211 scaffolds, and assigning a putative function to 2,559 (61%) 
CDS—the remainder are classified as hypothetical proteins. We additionally identified 1 
noncoding RNA (ncRNA), 105 tRNA, 46 complete rRNA genes, and 3 clustered regularly 
interspaced short palindromic repeat (CRISPR) arrays. 
One of the features that makes CV017 unique from C. violaceum ATCC31532 is a 
transposon that increases violacein expression [3]. We searched the CV017 draft genome to 
identify the transposon, previously described as a mercury-resistant mini-Tn5, and we found four 
mercury resistance genes (merBAPT) flanked by the conserved 19-bp Tn5 terminal ends [10]. 
This sequence resembles the mini-Tn5 Hgr from plasmid pUT/Hg [11]. This putative transposon 
element is located 66-bp upstream of the predicted ATG start site of a CDS located between 
11,559 and 11,975-bp on scaffold 184, a homolog of vioS in ATCC 12472 [12]. VioS is 




Based on current species delineation standards, two strains are said to be of the same 
species if they share greater than 70% DNA-DNA hybridization and 98% 16S rRNA similarity 
[13]. Using IGV to align the genomes of C. violaceum CV017 and C. violaceum ATCC 12472, 
we found that there is only a 65% sequence similarity. Since C. violaceum CV017 was not 
closely related to C. violaceum ATCC 12472, we constructed a dendrogram using 16S RNA of 
the 45 species with assemblies in NCBI. Based on neighbor-joining and maximum-parsimony, 
C. violaceum CV017 was grouped with other strains of C. subtsugae (Figure 1). Using IGV to 
align the genome of C. violaceum CV017 and C. subtsugae PRAA4-1, we found that there is 
PRAA4-1 share 98% sequence identity suggesting that C. violaceum CV017 is a member of the 




Figure 1. 16S rRNA Dendrogram of the genus Chromobacterium 
 
The 16S rRNA from C. violaceum CV017 (GenBank accession no. LKIW01000119.1) 
was used to construct a phylogenetic tree of 45 draft or complete genomes. Based on neighbor-
joining and supported by maximum-likelihood and maximum-parsimony, C. violaceum CV017 
was found to group with C. subtsugae not C. violaceum ATCC 12472,    .  
 
A comparison of C. subtsugae strain PRAA4-1 and C. violaceum ATCC 12472 identified 
a few key genes that are unique to or absent in C. subtsugae. This list includes: the presence of 
gene cluster MY55_RS12975–13045, the lack of the pgaABCD operon; lack of CV_RS01430-
01455, and the absence of Cpi-2 (pathogenicity island) [14]. To determine if C. violaceum 
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CV017 is really a member of the C. subtsugae species, we used BLAST to identify the presence 
or absence of the genes from this list in C. violaceum CV017. We found that CV017 also 
contains homologs for genes MY55_RS12975-13045, lacks the pgaABCD operon, and lacks the 
pathogenicity island Cpi-2, consistent with C. subtsugae. In pathogenicity island Cpi-1, C. 
subtsugae PRAA4-1 is also missing two hypothetical proteins when compared to ATCC 12472 
[15]. Interestingly, CV017 is missing those two hypothetical proteins and two additional genes 
(CV_RS12855 and CV_RS12860) from Cpi-1 that encode two secretory proteins associated with 
virulence. In Chapter III, we identified an antibiotic efflux pump, cdeABoprM. We used BLAST 
to search for homologs of this efflux pumps in the Chromobacterium genus. Interestingly, 
cdeABoprM is unique to C. subtsugae strains further supporting our hypothesis that CV017 is a 
member of the C. subtsugae species.  
The metabolic capabilities of CV017 are unknown but would provide further evidence of 
their membership to the C. subtsugae species. Unlike C. violaceum ATCC12472, C. subtsugae is 
unable to reduce nitrate and is oxidase positive. We performed a literature search to compare the 
metabolic and physical characteristics of a representative strain in each of the 11 species of 
Chromobacterium (Table 2). All species are similar in cell size and have one flagellum. Genome 
sizes ranges from 4.09 to 5.03Mbp with the average genome size of 4.74Mbp. All species that 
have been tested for hemolysis are able to lyse human red blood cells. Nitrate reduction, glucose 
fermentation, oxidase activity, and catalase activity all vary by species and could be used to 
differentiate speciation if genome sequencing is not possible. 
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Table 2. Summary of physical and metabolic characteristics of Chromobacterium species 
The table lists characteristics for each of the 11 species plus C. violaceum CV017 using the 
identified strain as the reference for each species. Every genome except for C. alkanivorans and 
C. rhizoryzae can be found in the NCBI assembly database.  
 
Discussion 
We were initially surprised by the lack of sequence identity between ATCC 12472 and 
CV017 since they were both classified as the same species. The overall length of the 
chromosome (4.8-kb) and %GC (64.5%) is consistent with most Chromobacterium species 
including C. violaceum and C. subtsugae [10]. Comparison of the CV017 scaffolds to the 
genome strain ATCC 12472 using MUMmer revealed that 64.4% of the bases in ATCC 12472 
were covered by assembled scaffolds [16]. Outside of these regions, nucleotide conservation 
between the two strains appears to be modest. CV017 and C. subtsugae have the same AHL 
signaling molecule (N-hexanoyl-homoserine lactone), a subtsugae specific secondary metabolite, 
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and the cdeABoprM efflux pump. Additionally, CV017 lacks many of the genes found in ATCC 
12472 including: pga operon, Cpi-2, and four genes found in Cpi-1. Our results based on 
sequence homology and phenotypic characterization strongly recommend the reclassification of 
C. violaceum CV017 as C. subtsugae CV017. For the sake of clarity throughout the rest of the 
dissertation, we will be referring to C. violaceum CV017 as Chromobacterium sp. CV017. 
The transposon insert that causes an increase in violacein is located upstream of a 
homolog of CV_1055. Interestingly, in another study nine transposon mutants of the parental 
strain ATCC 31532 that had a similar phenotype as CV017 (enhanced purple pigmentation) also 
mapped to a homolog of CV_1055 [17]. Likely, the mini-Tn5 in CV017 is inserted into the 
promoter region and disrupts expression of the CV_1055 homolog.  The function and structure 
of this protein is unknown. Homologs to CV_1055 can be found in every species that is known 
to produce violacein, so it is most likely a regulator of violacein. 
Understanding the phylogenetic relationship and unique metabolic characteristics of each 
species of Chromobacterium is important for establishing or updating biosafety guidelines for 
the new species of Chromobacterium. Many soil isolates of Chromobacterium are erroneously 
given the name of C. violaceum solely for their ability to produce violacein. However, all but 
four species of Chromobacterium produce violacein leading to many strains being incorrectly 
identified. This also has implications for the research of Chromobacterium as an emerging 
pathogen or for industrial purposes. Currently, most species of Chromobacterium are biosafety 
level 2 despite only C. violaceum and C. haemolyticum being associated with disease. Only the 
secondary metabolites from C. subtsugae and C. violaceum have been studied in detail leading to 
the identification of novel antibiotics, antitumor medications, an insecticide, and patent for 
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mercury free gold purification [6]. Changing the safety level will allow for easier access to study 
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Many Proteobacteria use quorum sensing to regulate production of public goods, such as 
antimicrobials and proteases, that are shared among members of a community. Public goods are 
vulnerable to exploitation by cheaters, such as quorum sensing-defective mutants. Quorum 
sensing-regulated private goods, goods that benefit only producing cells, can prevent the 
emergence of cheaters under certain growth conditions. Previously, we developed a laboratory 
co-culture model to investigate the importance of quorum-regulated antimicrobials during 
interspecies competition. In our model, Burkholderia thailandensis and Chromobacterium sp. 
CV017 each use quorum sensing-controlled antimicrobials to inhibit the other species’ growth.  
Here, we show that Chromobacterium sp. CV017 uses quorum sensing to increase resistance to 
bactobolin, a B. thailandensis antibiotic, by increasing transcription of a putative antibiotic efflux 
pump. We demonstrate conditions where Chromobacterium sp. CV017 quorum-defective 
cheaters emerge and show that in these conditions, bactobolin restrains cheaters. We also 
demonstrate that bactobolin restrains quorum-defective mutants in our co-culture model, and the 
increase in antimicrobial-producing cooperators drives the Chromobacterium sp. CV017 
population to become more competitive. Our results describe a mechanism of cheater restraint 
involving quorum-control of efflux pumps and demonstrate that interspecies competition can 





Many Proteobacteria use acyl-homoserine lactone (AHL) mediated quorum-sensing to 
regulate gene expression in a cell density-dependent manner [1-3]. AHLs are produced by LuxI-
family synthases and when they reach a sufficient concentration, the AHLs interact with 
cytoplasmic LuxR-family signal receptors to affect changes in gene transcription. Many quorum-
controlled genes encode factors, such as extracellular proteases, that can be shared among 
members of the population and constitute public goods [4]. Such public goods are cheatable by 
individuals that benefit without paying any costs of production [5]. In some conditions the 
cheaters can ultimately cause a population crash [6], presenting a significant threat to 
cooperation. Yet quorum-sensing mutants are relatively rare in some natural microbial 
populations [7, 8], suggesting there might be mechanisms to restrain cheating in certain contexts. 
One such mechanism relies on the quorum sensing-dependent linkage of private goods, such as 
cell-localized enzymes, with public goods. These private goods benefit only producing members 
of the population and have been shown to restrain cheating in some AHL-based quorum-sensing 
systems [6].  
 Many bacteria use quorum sensing to regulate the production of antimicrobials, a type of 
public good. For example, quorum sensing regulates the production of phenazine in 
Pseudomonas chlororaphis [9] and bactobolin antibiotic in Burkholderia thailandensis [10, 11]. 
Quorum-controlled antimicrobials are thought to be important for interspecies competition [12-
14]. Previously, we developed a laboratory dual-species model with the soil saprophytes 
Burkholderia thailandensis and Chromobacterium sp. CV017 to investigate the relationship 
between quorum sensing and interspecies competition [12]. The B. thailandensis bactobolin 
antibiotic targets the 50S ribosome and has activity against a range of bacterial species including 
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Chromobacterium sp. CV017 [11, 15, 16]. Bactobolin production is regulated by one of the three 
B. thailandensis LuxR-LuxI-type quorum-sensing pairs, BtaR2-BtaI2, that senses and produces 
the signals 3-hydroxy-octanoyl-homoserine lactone and 3-hydroxy-decanoyl-homoserine lactone 
[10]. In our dual-species model, B. thailandensis competitiveness relies upon the production of 
the bactobolin antibiotic and also BtaR2 [12]. Likewise, Chromobacterium sp. CV017 uses 
quorum sensing to control production of as-yet unknown secreted antimicrobials that are 
important to compete with B. thailandensis. In Chromobacterium sp. CV017, there is a single 
LuxR-LuxI pair, the CviR-CviI quorum-sensing system. The CviR-CviI system produces and 
responds to hexanoyl-homoserine lactone (C6-HSL) [17]. This system controls production of a 
purple pigment, violacein. Although violacein has broad-spectrum antimicrobial activity [18], 
the violacein biosynthetic genes were previously shown to be dispensable for competition in our 
dual-species model [12].  
We are interested in understanding how quorum sensing benefits bacteria in natural 
microbial communities, and how interspecies competition might shape the evolution of quorum-
sensing systems. Here we show that Chromobacterium sp. CV017 quorum sensing promotes 
resistance to bactobolin and several other antimicrobials through a CviR-dependent putative 
multidrug efflux pump. Because multidrug efflux pumps are cell-localized they might be 
considered a private good [19]. Here we show antibiotics restrain quorum sensing-defective 
mutants during serial passaging experiments and in direct competition with B. thailandensis. 
Such antibiotic-dependent selection might contribute to the maintenance of quorum sensing-
dependent behaviors important for competition, such as antimicrobial production. Our results 
provide a possible mechanism controlling quorum-defective cheater variants in natural microbial 
populations where interspecies interactions are common. 
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Materials and Methods 
Growth media, reagents and bacterial strains. Bacteria were grown in Luria-Bertani broth 
containing morpholinepropanesulfonic acid (50 mM; pH 7)(MOPS-LB), or in M9 minimal 
medium with 1% (wt/vol) of sodium caseinate (casein broth), or on LB with 1.5% (wt/vol) agar 
or skim milk agar (1/4-strength LB broth with 4% [wt/vol] skim milk and 1.5% [wt/vol] agar). 
All broth cultures were grown at 30°C with shaking at 230 r.p.m except Escherichia coli, which 
was at 37°C. Growth on solid medium was at 30°C for Chromobacterium sp. CV017 or 37°C for 
B. thailandensis and for Chromobacterium sp. CV017-E. coli matings. Growth in liquid cultures 
was with shaking at 30°C in 18-mm test tubes. Synthetic C6-HSL was purchased from Cayman 
Chemical (Ann Arbor, MI, USA) and dissolved in acidified ethyl acetate with glacial acetic acid 
(0.1 ml L-1). Dissolved C6-HSL was added to an empty sterile conical tube and dried by 
evaporation prior to the addition of LB agar that had been melted and cooled to 55°C. As a 
source of bactobolin, either filter-sterilized B. thailandensis culture fluid or purified bactobolin A 
was used (see Supplementary Information for additional information). Bactobolin A was 
suspended in sterile water prior to use in experiments. For casein evolution experiments we used 
tetracycline at 1 μg ml-1, bactobolin at 2 μg ml-1 and gentamicin at 12 μg ml-1. For strain 
constructions we used gentamicin at 50 μg ml-1 (Chromobacterium sp. CV017) or 15 μg ml-1 (E. 
coli). For selection from dual-species cultures, we used gentamicin at 100 μg ml-1 (B. 
thailandensis) and trimethoprim at 100 μg ml-1 (Chromobacterium sp. CV017).  
 Bacterial strains are listed in Table S1. B. thailandensis strains were E264 (wild type) or 
BD20, a bactobolin-deficient derivative of E264 [20]. Chromobacterium sp. CV017 strains are 
derivatives of strain ATCC31532 [21]. Chromobacterium sp. CV017 (referred to as wild type) 
has a transposon insertion in gene CV_RS05185 causing overexpression of violacein [22, 23], 
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CV026 is a derivative of CV017 with a second transposon insertion in the cviI gene [17], and 
CV026R is a derivative of CV026 with an in-frame deletion of the cviR gene [12]. The 
Chromobacterium sp. CV017 CdeAB-OprM- and CdeR H127Y mutants were constructed using 
homologous recombination as previously described [12] with synthetic gene fragments (IDT) 
cloned into the pEX18Gm-derived delivery plasmid [24]. For fragment cloning we used SphI-
XbaI (for ΔcdeAB-oprM) or HindIII-XbaI (for CdeR H127Y). The ΔcdeAB-oprM construct was 
made with ~500-bp DNA flanking cdeA and oprM resulting in a deletion of all but the first eight 
codons of cdeA and the last thirteen codons of oprM. The CdeR H127Y construct was made 
using a ~1000-bp DNA fragment encoding cdeR with a missense C379T mutation and ~100-bp 
DNA flanking cdeR. All candidate mutants were screened by PCR and susceptibility testing to 
gentamicin, the antibiotic resistance marker on the pEX18Gm delivery plasmid. All strains and 
PCR-generated plasmids were verified by PCR amplification and sequencing. 
Antibiotic sensitivity.  To determine antibiotic sensitivity, stationary-phase broth cultures were 
suspended to an optical density at 600 nm (OD600) of 1.0 and this suspension was serially diluted 
in 10-fold increments in LB broth. 10 μl aliquots of these successive dilutions were spotted onto 
LB agar plates containing antimicrobials at the concentration indicated or in a series of 
concentrations to determine the minimum inhibitory concentration (MIC). The agar plates were 
incubated at 30°C for 24 h and an additional 24 h at room temperature. The MIC was defined as 
the lowest concentration of antimicrobial in the plate that prevented visible growth of cells from 
the 10-3 dilution (~104 cells). B. thailandensis culture fluid was tested in 0.1% increments over a 
range from 0% to 7%, tetracycline was tested in 0.5 μg increments over a range from 0 to 2 μg 
per ml, ethidium bromide was tested in 10 μg increments in a range from 20 to 150 μg per ml, 
and gentamicin was tested in 0.1 μg increments in a range from 1 to 10 μg per ml.  
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Droplet digital PCR. RNA was harvested from stationary-phase Chromobacterium sp. CV017 
cells (OD600 of 4) using methods described previously [25]. Droplet digital PCR was performed 
on Bio-Rad’s QX200 Droplet Digital PCR (ddPCR) System using Eva Green Supermix. Each 
reaction used 1 ng μl-1 of cDNA template, 0.25 μM primer, 10 μl Eva Green Supermix, and 8 μl 
in a 20-μl volume. After generating 40 μl of oil droplets, 40 rounds of PCR were conducted 
using the following cycling conditions: 94°C for 20sec, 58°C for 20sec, and 72°C for 20sec. 
Absolute transcript levels were determined using the Bio-Rad QuantaSoft Software. In all cases a 
no template control was run with no detectable transcripts. The gene encoding glyceraldehyde-3-
phosphate dehydrogenase (gapdh) was used as a reference gene and the results are reported as 
the calculated transcript amount of a given gene per calculated gapdh transcript. 
Casein evolution experiments. To inoculate Chromobacterium sp. CV017 casein evolution 
experiments, a starter culture was prepared by diluting stationary-phase cells from an LB broth 
culture to an OD600 of 0.05 in casein broth and growing this for an additional 24 h. To start the 
experiment, 40 μl from this starter culture was transferred to 4 ml fresh casein broth and at 24 h 
intervals 40 μl was transferred to fresh casein broth in a new tube. Tetracycline and bactobolin 
were added to the culture medium every day. Gentamicin was added every other day for the first 
seven days and every day after that for the rest of the experiment. Colony forming units (CFUs) 
were determined by spread-plating 10-fold dilutions of the 24 h culture onto LB agar plates. 
Cheater abundance was determined by the proportion of colonies identified as cheaters compared 
with the rest of the population. Cheaters were identified based on complete loss of purple 
pigmentation due to abolished production of the quorum-dependent purple pigment violacein, 
and their inability to form a zone of clearing on skim milk -agar plates (skim milk clearing was 
described previously for P. aeruginosa [26, 27]). Although intermediate-phenotype variants were 
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occasionally observed (partial pigmentation and protease production), only those variants with 
complete loss of each phenotype (similar to the quorum-sensing defective mutants) were counted 
as cheaters. As described in the text, a subset of cheaters was also verified by sequencing the 
cviR gene.  
Dual-species experiments. Dual-species experiments were conducted in 1 ml MOPS-LB broth in 
18 mm test tubes. The inoculum was from logarithmic-stage pure cultures of B. thailandensis 
and Chromobacterium sp. CV017. The initial OD600 in the dual-species culture was 0.05 (2-4 x 
107 cells per ml) for B. thailandensis and 0.005 (2-4 x 106 cells per ml) for Chromobacterium 
sp. CV017. When indicated, Chromobacterium sp. CV017 wild type and CviIR- mutant cells 
were combined at a 1:1 ratio just prior to mixing with B. thailandensis. Colony forming units of 
each species were determined by using differential antibiotic selection on LB agar plates. B. 
thailandensis was selected with gentamicin and Chromobacterium sp. CV017 was selected with 
trimethoprim. Wild type and the CviIR- mutant were differentiated by color as described above. 
Results 
Chromobacterium sp. CV017 quorum sensing is important for antimicrobial resistance. 
In transcriptomics studies of saprophytic Proteobacteria, quorum sensing commonly 
activates expression of genes predicted to be responsible for antibiotic export [28-31]. Because 
some efflux pumps increase antimicrobial resistance, this finding suggests there might be a 
connection between quorum sensing and antimicrobial resistance. Using our B. thailandensis-
Chromobacterium sp. CV017 laboratory model as a starting point, we sought to test the 
hypothesis that Chromobacterium sp. CV017 quorum sensing might increase resistance to the B. 
thailandensis bactobolin antibiotic. To test this hypothesis, we supplemented Luria-Bertani (LB) 
agar plates with B. thailandensis culture fluid and compared the growth of Chromobacterium sp. 
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CV017 wild type and two quorum sensing-deficient mutants, an AHL synthase mutant (CviI-) 
and an AHL synthase and receptor double mutant (CviIR-) by spotting 10-fold dilutions from 
stationary-phase cultures onto the plates (Fig. 1 and Table 1).  
Figure 1 Quorum sensing increases Chromobacterium 
sp. CV017 resistance to antimicrobials 
 
Growth of Chromobacterium sp. CV017 wild type (WT) 
or the AHL synthase, receptor double mutant (CviIR-). 
The WT is purple due to production of the quorum 
sensing-dependent purple pigment violacein. Stationary-
phase cultures were prepared in 10-fold serial dilutions in 
Luria-Bertani broth, and 10μl of each successive dilution 
was spotted from left to right onto LB agar alone (top 
panel), LB agar containing 0.5% B. thailandensis culture 
fluid (as a source of bactobolin, see Methods), 1% culture 
fluid from bactobolin-deficient B. thailandensis strain 
(BD20), 0.4μg per ml gentamicin (gent). Photos were 
taken after 24h growth at 30⁰C and an additional 24h 
growth at room temperature. 
 
We determined that wild-type Chromobacterium sp. CV017 was more resistant to B. 
thailandensis culture fluid than either of the quorum-sensing mutants, with a minimum inhibitory 
concentration (MIC) of 1.6% compared to 0.5% or 0.6% for CviIR- and CviI-, respectively. We 
could rescue resistance to the AHL synthase mutant by supplementing the LB agar plate with 
synthetic C6-HSL, the AHL specific to CviR (Table 1). The wild type and each of the quorum-
sensing mutants grew identically on LB agar with or without supplementation with 3% cell-free 
fluid from a B. thailandensis bactobolin-deficient mutant (data not shown). These results 
indicated Chromobacterium sp. CV017 quorum sensing is important for bactobolin resistance.  
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 Table 1. Antimicrobial susceptibility of Chromobacterium sp. CV017 strains 
aThe minimum inhibitory concentration (MIC) of B. thailandensis culture fluid (Bt fluid), 
tetracycline (Tet), ethidium bromide (EtBr) or gentamicin (Gent) was determined by spotting 
~104 Chromobacterium sp. CV017 stationary-phase cells of the indicated strain onto LB agar 
containing a range of antimicrobial concentrations as described in Materials and Methods. 
Results are the average of three independent experiments and the standard deviation is in 
parentheses when it was not zero. Statistical analysis by t test compared with wild type under 
each treatment condition: *, p ≤ 0.0001. For ethidium bromide, no p-value was given because 
there was no variation (standard error is 0). For gentamicin, none of the averages significantly 
differed from wild type. 
bResults are from a single preparation of B. thailandensis fluid. Results with other preparations 
were similar. There were no observed growth defects in identical experiments with 3% culture 
fluid from a B. thailandensis bactobolin-deficient mutant.  
cND, not determined. 
dCviIR- BR refers to spontaneous bactobolin-resistant isolates. Two isolates were tested, and 
results were identical. 
 
We also evaluated the importance of quorum sensing for resistance to other 
antimicrobials. We tested growth of our Chromobacterium sp. CV017 strains on plates 
supplemented with the antimicrobials tetracycline, gentamicin or ethidium bromide. Our results 
showed that quorum sensing increases Chromobacterium sp. CV017 resistance to tetracycline 
and ethidium bromide but had no effect on gentamicin susceptibility (Fig. 1 and Table 1). 
Altogether our results support the conclusion that Chromobacterium sp. CV017 quorum sensing 
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regulates resistance to several antimicrobials, including bactobolin. Our results are consistent 
with the idea that the quorum sensing-controlled resistance factor is an efflux pump. Antibiotic 
efflux pumps commonly confer resistance to a subset of antibiotics with unrelated mechanisms 
of action, and they are frequently associated with ethidium bromide resistance [32].  
Quorum sensing controls antimicrobial resistance through a putative efflux pump. 
To identify the genetic factors responsible for quorum sensing-dependent antibiotic 
resistance, we isolated spontaneous bactobolin-resistant mutants and defined the mutations 
leading to resistance using a whole-genome sequencing approach. We chose this approach 
because antibiotic resistance mechanisms are not well understood in Chromobacterium sp. 
CV017 [23], and because initial genetic mutations that increase resistance often occur through 
efflux pumps, providing a relatively simple approach to identify efflux pumps with specificity 
for bactobolin [33, 34]. We isolated bactobolin-resistant mutants by spread-plating about 108 
cells of the sensitive Chromobacterium sp. CV017 AHL synthase, receptor double mutant onto 
LB agar supplemented with ~0.6% B. thailandensis culture fluid, the minimal concentration 
needed to inhibit growth of this strain. Colonies arose after two days at 30⁰C, and two mutants 
were isolated by streaking onto LB agar with 0.6% B. thailandensis culture fluid. We used a 
previously-described approach [15], detailed in the Supplementary Information, to isolate two 
bactobolin-resistant variants in the otherwise sensitive CviIR- mutant. [12] We assessed the 
antimicrobial susceptibility profiles of each variant relative to the parent strain. Results were 
identical for each variant and are described in Table 1 (strain CviIR- BR). Both variants were 
more resistant than the parent to bactobolin, tetracycline and ethidium bromide, but there was no 
difference in resistance to gentamicin, (Table 1), similar to the quorum sensing-dependent 
antimicrobial resistance profile described above. To define the mutations involved in bactobolin 
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resistance, we sequenced the genomes of our bactobolin-resistant variants using an Illumina 
platform (see Supplementary Information). The variants both had 11 identical single nucleotide 
polymorphisms (SNPs) when compared to the sequenced strain CV017 (Wang et al 2016). Two 
of these were in putative antibiotic resistance genes. When we PCR-amplified and sequenced the 
two SNP sites, only one was mutated in both variants relative to CV017. This was a C379T 
mutation in a predicted TetR family transcriptional regulator CV017_15440, coding for the 
mutation H127Y. CV017_15440 is upstream and divergent to a 3-gene cluster with homology to 
resistance nodulation division (RND) efflux pumps in other Proteobacteria, such as mexAB-oprM 
from Pseudomonas aeruginosa [35]. We named the TetR-family gene cdeR and the downstream 
genes cdeAB-oprM (Chromobacterium drug exporter).  
We sought to determine whether the H127Y mutation in CdeR increased bactobolin 
resistance and if cdeAB-oprM is responsible for the quorum-dependent antibiotic resistance 
phenotype we had observed. We introduced the allele encoding CdeR H127Y into the genome of 
the Chromobacterium sp. CV017 AHL synthase mutant at the native cdeR locus. The engineered 
CdeR H127Y mutant demonstrated the same antimicrobial susceptibility profile as the 
bactobolin-resistant variants (Table 1), confirming the increased antimicrobial resistance is due 
to the CdeR H127Y mutation. We subsequently deleted the cdeAB-oprM genes in the wild type 
and quorum sensing-defective CviIR- mutant. Deletion of cdeAB-oprM resulted in a ~6-fold 
decrease in bactobolin resistance relative to the wild type and similar decreases in resistance for 
tetracycline and ethidium bromide (Table 1). Importantly, the loss of quorum sensing did not 
further decrease antibiotic sensitivity of the CdeAB-OprM-deficient mutant (Table 1, compare 
the CdeAB-OprM- mutant to the CdeAB-OprM-, CviIR- mutant), supporting the idea that 
quorum sensing-dependent antibiotic resistance occurs through the CdeAB-OprM putative efflux 
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pump. In support of this idea, both cdeA and cdeB transcripts were ~15-fold higher in wild-type 
cells compared with identically grown CviIR- mutant cells (Fig. 2), demonstrating that quorum 
sensing activates transcription of these genes. The genes were also activated in one of the 
spontaneous bactobolin-resistant variants, suggesting that increased resistance in this strain 
might have been due to increased transcription of the cdeAB-oprM genes.  
Figure 2 Quorum sensing induction of cdeA and cdeB transcription 
Quantitative digital PCR was used to quantify cdeA 
and cdeB transcripts in cells from stationary-phase 
cultures (optical density of 600nm [OD600] of 4). 
Shown are cdeA and cdeB transcripts from wild type 
(WT, black bars), and the AHL synthase, receptor 
double mutant (CviIR-, gray bars), and the 
bactobolin-resistant double mutant (CviIR- BR, white 
bars). In all cases, results were normalized to the 
housekeeping gene, glyceraldehyde-3-phosphatase 
dehydrogenase (gapdh). The values represent the average of three independent experiments and 
the error bars represent the standard deviation. Statistical analysis by t-test compared with wild 
type: *, p ≤ 0.005, **, p ≤ 0.05. 
 
Antibiotics suppress the emergence of Chromobacterium sp. CV017 cheaters during passage in 
casein broth 
Because CdeAB-OprM is a predicted efflux pump, and efflux pumps are membrane-
localized, we hypothesized that CdeAB-OprM might be a type of quorum-controlled private 
good that can restrain cheating during growth with antibiotics. Previous studies of Pseudomonas 
aeruginosa and Vibrio cholerae demonstrated the necessity of secreted quorum sensing-
dependent proteases for growth on casein as the sole carbon and energy source and, after 
prolonged passaging in these conditions, quorum sensing-deficient cheaters emerge [26, 27, 36]. 
Initially, we assessed the ability of wild type and a quorum sensing-deficient (CviIR-) 
Chromobacterium sp. CV017 mutant to grow in minimal casein broth and proteolyze skim milk 
protein (Fig. 3A). Wild type, but not the CviIR- mutant could grow on casein and form a zone of 
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clearing on skim milk agar (Fig. 3A), consistent with the conclusion that a quorum-dependent 
protease is required for Chromobacterium sp. CV017 to grow on casein.  
Figure 3 Protein degradation and cheater emergence during Chromobacterium sp. CV017 growth 
on protein 
A. Growth of Chromobacterium sp. 
CV017 wild type and the AHL 
synthase, receptor double mutant 
(CviIR-) after growth in minimal 
casein broth or on skim milk agar. 
Only wild type can hydrolyze the 
casein in both types of media.  
B. Emergence of cheaters in 
Chromobacterium sp. CV017 
populations passaged in casein 
broth. Cultures were transferred 
daily, and every 2-3 days, cheater 
abundance was determined just prior to sub-culture by dilution planting onto Luria-Bertani agar and 
enumerating the yellow colonies that also did not form a zone of proteolysis when patched onto skim 
milk agar plates. Each black line represents an independent experiment. In all three experiments, cheaters 
emerged after 2-10 days and their abundance rose of >80% of the population, followed by termination of 
the experiment when there was no growth after transfer. C. Location of nucleotide mutations in 
Chromobacterium sp. CV017 cheaters mapped to the CviR amino-acid sequence. Each unique amino-
acid substitution or early termination is shown the illustration and indicated in Table S2. The AHL- and 
DNA-binding domains of CviR are indicated. 
Having established that Chromobacterium sp. CV017 requires quorum sensing to grow 
on casein, we assessed the emergence of quorum sensing-defective cheaters by passaging a 
Chromobacterium sp. CV017 population every day into fresh casein growth media and spread-
plating dilutions of the culture onto LB agar every 2-3 days to enumerate the frequency of 
cheaters (see Materials and Methods). Cheaters were identified as yellow colonies (due to loss of 
violacein production) that also did not form a zone of proteolysis when patched onto skim milk 
agar plates. We also sequenced the quorum-sensing receptor cviR in 10 of these putative mutants 
and in each case, there was a mutation in cviR (Table S2 and Fig. 3C). In three independent 
experiments (shown as three separate black lines in Fig. 3B), cheaters emerged between 2-10 
days. At a frequency of >80% cheaters, the culture failed to grow after transferring due to a 
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population collapse (Fig. 3B, open triangles). The emergence of quorum sensing receptor-
mutated cheaters in the population and ultimate population collapse was similar to that 
previously reported for P. aeruginosa [6, 26, 27].  
In P. aeruginosa, quorum sensing co-regulates the expression of a secreted protease and a 
cellular enzyme, nuh, that promotes adenosine utilization, and growth on adenosine restrains the 
emergence of cheaters [6]. To test our hypothesis that antibiotics might similarly restrain cheater 
emergence in Chromobacterium sp. CV017, we added tetracycline or purified bactobolin A to 
our casein growth experiments (Fig. 4). Wild-type cultures could be passaged serially with a 
maximum antibiotic concentration of either 2 μg ml-1 bactobolin A or 0.25 μg ml-1 tetracycline, 
which caused a maximum of a 1-log reduction of the final population yield relative to cultures 
grown with no antibiotic (Fig. S1). In the presence of either antibiotic, cheaters remained below 
the limit of detection (Fig. 4, dashed line) and the population yield remained consistent 
throughout the experiment (Fig. S1). However, it appeared that only antibiotic substrates of 
CdeAB-OprM were able to restrain cheaters, because cheaters emerged in populations grown 
with growth-inhibitive concentrations of gentamicin, which is not targeted by quorum sensing or 
CdeAB-OprM (Table 1). Interestingly, during our experiments, populations grown with 
gentamicin never crashed as we observed in populations grown in the absence of any antibiotics 
(Fig. 4). These results might suggest a potentially unmeasurable quorum sensing-dependent 
effect on gentamicin resistance or an indirect effect of gentamicin, for example through increased 




Figure 4 Antibiotics suppress Chromobacterium sp. CV017 cheaters in casein broth. 
Cultures were grown as described in Fig. 3 except 
the culture media was supplemented with 
antibiotics. The solid lines show two independent 
experiments of populations passaged with 12 μg 
ml-1 gentamicin. The dashed line shows 
populations passaged with 2 μg ml-1 bactobolin A 
or 0.25 μg ml-1 tetracycline (two independent 
experiments were conducted with each antibiotic 
and results were identical in all cases). All 
antibiotic-treated populations were passaged in 
parallel with populations grown without antibiotics (partially represented in Fig. 3). In all cases, 
in populations grown without antibiotics cheaters emerged within 2-10 days and reached >80% 
of the population by the end of the experiment. 
Bactobolin restricts growth of quorum sensing-deficient Chromobacterium sp. CV017 mutants in 
dual-species cultures 
The sensitivity of Chromobacterium sp. CV017 quorum sensing-defective mutants to 
bactobolin suggests these mutants may be growth-inhibited during direct competition with B. 
thailandensis. To test this hypothesis, we used our genetically engineered Chromobacterium sp. 
CV017 AHL synthase, receptor double mutant (CviIR-). Our approach was a modification of the 
methods used previously to grow Chromobacterium sp. CV017-B. thailandensis cultures [12]. In 
our experiments, Chromobacterium sp. CV017 wild type and CviIR- mutant were mixed at a 1:1 
ratio prior to combining with B. thailandensis (see Materials and Methods and [12]). As controls, 
we also grew the Chromobacterium sp. CV017 mixture without B. thailandensis or with a B. 
thailandensis bactobolin-deficient mutant. At the start and end of each experiment we 
determined the proportion of each Chromobacterium sp. CV017 strain by first spread-plating the 
entire Chromobacterium sp. CV017 population onto agar containing trimethoprim to select for 
Chromobacterium sp. CV017 and then enumerating the yellow (CviIR- mutant) colonies as a 
proportion of the total Chromobacterium sp. CV017 population (Fig. 5). During growth with B. 
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thailandensis, the CviIR- mutant decreased from 50% to 17% of the total Chromobacterium sp. 
CV017 population. In contrast, when grown with no B. thailandensis or with the bactobolin-
defective B. thailandensis, the CviIR- mutant population increased from 50% to more than 90% 
of the total Chromobacterium sp. CV017 population. These results show B. thailandensis-
produced bactobolin selects against CviIR- mutants, supporting the idea that bactobolin stabilizes 
Chromobacterium sp. CV017 quorum sensing during competition.  
Figure 5 Competition increases the proportion of wild-type Chromobacterium sp. CV017 
relative to quorum sensing-defective mutants 
Chromobacterium sp. CV017 wild type or a 
quorum sensing-deficient mutant (CviIR-) were 
mixed at a 1:1 ratio then either combined with 
wild-type B. thailandensis or a bactobolin-
deficient B. thailandensis mutant (Bacto-, strain 
BD20), or grown with no B. thailandensis as 
described in the text. The percent CviIR- 
mutants within the Chromobacterium sp. 
CV017 population was determined by counting 
the yellow colonies as a percent of the total 
Chromobacterium sp. CV017 population 
isolated on selective agar. The dashed line 
indicates the initial percent CviIR-. Shown is the mean of four independent experiments and the 
error represents the standard deviation. Statistical analysis by Mann-Whitney nonparametric test 
compared to wild type: *, p = 0.0286.  
Because bactobolin increases the frequency of selects Chromobacterium sp. CV017 
quorum-sensing cells (Fig. 5), and quorum sensing controls production of antimicrobials [12], 
we hypothesized that changes in the frequency of Chromobacterium sp. CV017 quorum-sensing 
cells would influence the outcome of competition with B. thailandensis. To test this hypothesis, 
we varied the starting ratio of wild type and CviIR- Chromobacterium sp. CV017 cells in our 
competition experiments with B. thailandensis. We used a Chromobacterium sp. CV017 starting 
ratio of 9:1 and 1:9 wild type to CviIR-, similar to the ratios observed at the end of the 
competition experiments described in Fig. 5. Our results showed that the higher frequency of 
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wild-type Chromobacterium sp. CV017 correlated with lower B. thailandensis growth (Fig. 6). 
Thus, altering the frequency of wild-type Chromobacterium sp. CV017 can influence the 
competitive ability of the Chromobacterium sp. CV017 population. Together, our results support 
the idea that antibiotic stabilization of quorum sensing can increase competitiveness. 
Figure 6 Chromobacterium sp. CV017 competitiveness correlates with the frequency of 
wild type relative to quorum sensing-deficient mutants 
Chromobacterium sp. CV017 wild type or a 
quorum sensing-deficient mutant (CviIR-) cells 
were mixed together at a 1:9 or 9:1 ratio and 
then combined with wild-type B. thailandensis 
and grown for 24h. The final B. thailandensis 
density was determined by selective plating and 
colony counts. The solid lines represent the 
means for each group. The vertical bars 
represent the standard deviation of each group. 
Statistical analysis by paired t-test compared 
with wild type: *, p = 0.0468. Paired groups are 
indicated by color and represent experiments 
performed in parallel on different days. 
 
Discussion 
In many Proteobacteria quorum sensing activates dozens to hundreds of genes, including 
those coding for secreted or excreted public goods, that are important for cooperation. 
Cooperating populations are threatened by quorum sensing-deficient cheaters, individuals 
utilizing the public goods without paying any cost for their production. Cheaters typically have a 
growth advantage over cooperators and their proliferation may ultimately cause the cooperative 
behavior to be lost. However, the maintenance of cooperation in natural populations suggests 
there are diverse mechanisms of cheater control across different bacterial groups. Indeed, several 
such mechanisms have been described, including kin selection through spatial structure [38, 39], 
mechanisms that allow cooperators to specifically recognize and interact with other cooperators 
(e.g. greenbeard traits) [40, 41], and pleiotropy, or co-regulation of genes coding for self-
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benefiting private activities and genes coding for freely shared public goods [6, 42]. Results of 
this study demonstrate a type of pleiotropy dependent on antibiotics produced by other species, 
Cheater control by other species has also been shown to occur through nutrient competition [43], 
and through selective grazing of cheaters by protists [44, 45]. Our study expands the list of 
known mechanisms of cheater control and provides additional support of the idea that cheaters 
can be controlled through interspecies or interkingdom interactions  
The results of this study demonstrate cheater control by antibiotics occurs through 
quorum control of antibiotic resistance through an efflux pump. What factors might contribute to 
maintenance of quorum-controlled resistance? The ecological or physiological factors that favor 
quorum-control of efflux pumps are as-yet unknown, however, it is unlikely that cheater control 
is sufficient for such selection [46]. Efflux pumps are known to have some fitness cost [47] thus 
using quorum sensing to control efflux pump production might mitigate fitness costs at low 
density as a means to optimize growth. Quorum sensing also commonly controls secreted toxin 
production, and quorum-sensing regulation of efflux pumps might serve to prevent self-toxicity. 
Chromobacterium sp. CV017 itself produces several antimicrobials, including the quorum 
sensing-regulated antibiotic violacein [17, 48]. However, in our experiments, CdeAB-OprM does 
not appear to prevent self-toxicity, as the quorum-defective variants are not growth-inhibited by 
the wild-type parent when the two strains are grown in co-culture, in fact, the mutants are more 
fit than the parent (Figs. 3 and 5).  
 Quorum sensing-dependent antibiotic resistance might also be important for competing 
with other strains or species in multispecies communities. Quorum sensing might be one of 
several systems involved in ‘competition sensing’ [49], providing an indirect measurement of the 
potential for competitors in the surrounding environment. As the population density increases, 
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nutrients and space become limited and there is an increased potential for conflicts with 
neighbors. Thus quorum-sensing systems might coordinate production of several factors, 
including antibiotic resistance determinants, which promote survival when competition is likely. 
Quorum sensing might also activate the production of efflux pumps when they directly detect 
competitors by sensing and responding to their signals through eavesdropping [12]. Broad 
signal-specificity receptors in some saprophytic species such as Chromobacterium sp. CV017 
and P. aeruginosa might serve in this capacity [17, 50].  
There is some evidence suggesting quorum-sensing control of antimicrobial resistance is 
not limited to Chromobacterium sp. CV017. Quorum sensing has also been reported to control 
resistance to tobramycin in biofilm-grown P. aeruginosa [51]. In Escherichia coli, a quorum-
sensing receptor increases resistance to quinolones and several other antibiotics [52, 53]. 
Quorum sensing also activates expression of genes predicted to encode multidrug efflux pumps 
in other Proteobacteria [28-31], which may have important implications in treating infections if 
these antibiotics contribute to the selection or maintenance of quorum sensing or ‘rewiring’ of 
quorum-sensing systems during infections [54]. 
Our results indicate quorum sensing in Chromobacterium sp. CV017 controls antibiotic 
resistance through the CdeAB-OprM putative efflux pump. The genes encoding CdeAB-OprM 
share sequence and structural similarity to other resistance nodulation division (RND) efflux 
pump genes. RND efflux pumps have three proteins, an inner membrane transporter (efflux) 
protein (CdeB), a periplasmic accessory protein (CdeA) and an outer membrane channel (OprM) 
(for a review, see ref. [32]. RND efflux pump genes are frequently linked to a TetR-family 
regulator gene, and in the case of CdeAB-OprM, this appears to be CdeR. TetR-family members 
typically act as repressors by binding to a site in the promoter of the first efflux pump gene 
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through a N-terminal DNA-binding domain. De-repression occurs when the C-terminal ligand-
binding domain interacts with ligand (e g. tetracycline). In many bacteria with RND efflux 
pumps, antibiotic resistance mutations map to the efflux pump regulator, typically the N-terminal 
DNA-binding domain, and cause de-repression (reviewed in [32]). The H127Y mutation in CdeR 
is in the N-terminal domain and might similarly affect CdeR, causing de-repression of cdeAB-
oprM, although the role of CdeR as a repressor has not been experimentally determined. The 
hypothesis that CviR directly regulates cdeR, cdeA, or both can be tested experimentally, and 
such studies might provide insight into the mechanism of efflux pump regulation by quorum 





Materials and Methods 
Preparation of bactobolin and bactobolin purification. As a source of bactobolin, we used 
filtered B. thailandensis culture fluid or purified bactobolin A, the most potent of eight 
bactobolins produced by B. thailandensis [55]. B. thailandensis culture fluid was prepared as 
follows: B. thailandensis was grown to stationary phase (optical density at 600 nm [OD600] of 8 
to 10) in LB broth, and the culture fluid was clarified by centrifugation and filtered through a 
0.22-m pore membrane. Filtered culture fluid was stored at 4°C for up to 1 month prior to use 
and either used directly for experiments or used to purify bactobolin A as follows using a 
modified procedure similar to that reported previously [11]. The aqueous culture fluid containing 
bactobolin was concentrated to a residue by rotovap and then purified by reversed phase 
chromatography using an automated purification system capable of triggering fraction collection 
based on the mass signal of bactobolin. Two complementary chromatographic conditions were 
used.  For the first condition, the bolus of dried residue was taken up in DMSO to produce a 
90ml sample solution which was injected automatically in 30 preparative runs totaling 6 hours 
utilizing a 5 m Waters Atlantis T3 19 x 150 mm column, an aqueous phase of 0.1% formic 
acid, a flow rate of 20 ml min-1, and a gradient of 10% to 30% acetonitrile over 5 minutes.  For 
the second condition it was necessary to raise the pH of the mobile phase to achieve separation 
of the few remaining impurities.  The same column, flow rate, and fraction triggering were used 
but the aqueous phase was 10 mM ammonium acetate at pH 6.9 and the gradient was 5% to 50% 
acetonitrile over 8 minutes. A total of 5 injections of 1ml each in DMSO were performed with 
this condition. A final cleanup of one injection was performed using the first condition to achieve 
a final purity of 93.8% (auc @ 214nm) and a recovery of 16.1 mg. All preparative runs were 
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performed on an Agilent 1200 purification system with HTS PAL autosampler and an Agilent 
6120 mass spectrometer. 
Isolation and sequencing of bactobolin-resistant Chromobacterium sp. CV017 mutants. To 
isolate bactobolin-resistant Chromobacterium sp. CV017 mutants, we used a method similar to 
that described previously [15]. Briefly, ~1x108 stationary-phase Chromobacterium sp. CV017 
strain CV026R cells were spread onto LB agar plates containing, as a source of bactobolin, filter-
sterilized B. thailandensis culture fluid (from stationary-phase cultures, optical density [OD600] 
8-10, at a 0.5% final concentration). Colonies arose after two days at 30C, and two mutants 
were isolated by streaking onto LB agar with 0.6% B. thailandensis culture fluid. DNA was 
isolated from bactobolin-resistant clones and used to make sequencing libraries with 300-bp 
inserts. The libraries were sequenced on an Illumina HiSeq 2500 System in high output mode, 
generating 100-bp single reads. Raw paired-end reads from the CV017 strain were preprocessed 
with Scythe (v0.991, https://github.com/vsbuffalo/scythe) and Sickle (v1.200, 
https://github.com/najoshi/sickle) to improve read quality. Initial mapping of the trimmed reads 
to the reference strain (ATCC 12472, accession NC_005085.1) revealed modest nucleotide 
conservation between strains. Thus, trimmed reads were de novo assembled using Velvet 
(v1.2.09, [56]) to build contigs for downstream variant discovery. Using an empirically 
determined, optimal k-mer size of 51, we generated 515 scaffolds with an N50 scaffold size of 
18,607-bp and a summed length of 4,655,291-bp. Subsequently, we independently aligned 
trimmed reads from mutant strains BR1 and BR2 to the CV017 de novo genome build using 
BWA (v0.7.7, [57]), and used SAMtools (v0.1.18, [58, 59]) mpileup method to call variants. 
This yielded a list of both single nucleotide polymorphisms (SNPs) and insertion-deletion 
variants differing between each mutant strain and CV017 progenitor. We extracted all 
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homozygous variants, and used MUMmer (v3.23, [60]) to locate the contigs containing these 
variants to ATCC 12472, allowing us to annotate variants in conserved sequence regions. Using 
this procedure, we identified 7 single nucleotide polymorphisms in each of BR1 and BR2 that 
were genic and nonsynonymous. We subsequently focused on the mutation in cdeR because it 
was in a gene homologous to that identified in a similar previous screen of bactobolin resistant 
variants in Burkholderia vietnamiensis (Chandler and Greenberg, unpublished). The mutation in 




Table S1. Bacterial strains used in this study 
 
Strain or 




E264 Wild-type strain [20] 
BD20 btaK (bactobolin) mutant of E264 [10] 
Chromobacterium sp. CV017 
ATCC 31532 ATCC type strain ATCC 
CV017 Uncharacterized mini-Tn5 mutant of ATCC 31532 [17] 
CV026 cviI::Tn5 xylE Kmr insertion mutant of CV017  [17, 61] 
CV026R cviR mutant of Cv026  This study 
CV026R BR1 Spontaneous bactobolin-resistant mutant This study 
CV026R BR2 Spontaneous bactobolin-resistant mutant This study 
CV026 H127Y CdeR Engineered bactobolin-resistant mutant This study 
CV017 ∆cdeAB-oprM cdeAB-oprM mutant of CV017 This study 
CV026R ∆cdeAB-oprM cdeAB-oprM mutant of CV026R This study 
Plasmid 
pEX18Gm Suicide vector [24] 
pEX18Gm CdeR H127Y  Deletion construct used to make This study 
Cv026R CdeR H127Y 
pEX18Gm ∆cdeAB-oprM Deletion construct used to make This study 
 CV017 ∆cdeAB-oprM and  





Table S2. Chromobacterium sp. CV017 quorum-sensing cheater variants 
Variant  Experimenta  cviR mutationb  Amino acid changec 
cviR1  No antibiotic 1 (8) T→C (+261)   Y88H  
cviR2  No antibiotic 1 (24) G→C (+451)   G151R 
cviR3  No antibiotic 2 (13) AGC (+411-413)  138S  
cviR4  No antibiotic 2 (13) T→C (+253)   L85P 
cviR5  No antibiotic 3 (17)  (+553 to +564)  Truncation (239) 
cviR6  No antibiotic 3 (19) GAG (+410-413)  138E 
cviR7  No antibiotic 4 (13) C→T (+58)   Truncation (20) 
cviR8  No antibiotic 4 (15) C→T (+301)   Truncation (101) 
cviR9  Gentamicin 1 (9) A→C (+689)   K230T 
cviR10  Gentamicin 1 (10) T→C (+510)   S155P 
 
aTwo cheaters were sequenced from each of four experiments where no antibiotic was added, 
and one experiment where gentamicin was added. Isolates were taken on the days shown in 
parentheses.  
bNucleotide changes relative to the translational start site of CV017 cviR. 




Figure S1 Growth yield of casein-passaged cultures 
 
One representative experiment from each of the following conditions is shown: cultures grown 
with no antibiotic (blue line), with 2 g ml-1 bactobolin A (red line), 0.25 g ml-1 tetracycline 
(black line) or 12 g ml-1 gentamicin (green line). Cultures were transferred daily and, every 2-3 
days, the growth yield was determined just prior to subculture by dilution plating onto Luria-
Bertani agar and enumerating the total number of colonies.  
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CHAPTER IV:  
Signal promiscuity of the quorum sensing receptor, CviR, in Chromobacterium sp. CV017 




C. violaceum has been widely used as a biosensor to detect short-chain acyl-homoserine 
lactones (AHLs) produced by other bacteria. The ability to respond to other species’ AHLs, or 
‘eavesdropping,’ may help C. violaceum compete with other strains or species in polymicrobial 
communities. Previous research in our lab and other labs has demonstrated that 
Chromobacterium sp. CV026 can detect AHLs produced by Burkholderia thailandensis [1]. We 
demonstrate that CviR in Chromobacterium sp. CV017 can respond to N-octanoyl-L-homoserine 
lactone (C8-HSL) and N-3-hydroxyoctanoyl-L-homoserine lactone (3OH-C8-HSL) and this 
response provides an increase in Chromobacterium sp. CV017 competitiveness during 
competition with B. thailandensis. CviR is known to have a broad range of AHL specificity, but 
the genes regulated by CviR in response to both cognate and noncognate AHLs are unknown. 
Our transcriptome analysis of genes that respond to various AHLs reveals that there is a subset of 






 Acyl-homoserine lactone (AHL) mediated quorum sensing (QS) systems have been 
found in many Proteobacteria and typically involve two genes coding for a LuxI-family AHL 
synthase and a LuxR-family AHL receptor and transcription regulator [2]. The AHL signal is 
diffusible, and after reaching a critical concentration, the signal binds its cognate LuxR receptor. 
Usually an AHL synthase produces one main AHL and several other AHLs at low levels [3]. 
However, the AHL receptor is specific for just the main product of the AHL synthase. There are 
a few notable exceptions to this dogma, including Chromobacterium violaceum, which has been 
shown to bind AHLs of varying acyl-side chains [4]. 
In most LuxR-homologs, noncognate signals cannot bind because the acyl-side chains do 
not fit in the AHL binding site. However, in C. violaceum noncognate AHLs have been shown to 
activate expression of the purple pigment, violacein [4]. Crystal structures of CviR with various 
signals show that CviR accommodates longer side chains by allowing the side chain to protrude 
from the binding site [5]. However, this does affect the overall confirmation of the CviR 
homodimer. When the CviR homodimer is bound to noncognate AHLs, the DNA binding 
domains begin to move farther apart [5]. This conformation is similar to the “locked” structure 
that is observed when a QS inhibitor, chlorolactone, is in the AHL binding site. In the “locked” 
conformation, the DNA binding domains are so far apart that no DNA binding can occur. This 
may explain why CviR binds cognate signal with the strongest affinity and that this affinity 
decreases as the acyl side chain length increases. The binding affinity of CviR for AHLs also 
corresponds to the level of violacein expression allowing us to measure violacein expression as a 
proxy for AHL binding affinity [4, 6].  
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The advantage of CviR binding to noncognate signals is unclear. However, it has been 
proposed that this ability to ‘eavesdrop’ on other species might be important for 
Chromobacterium sp. CV017 survival in multi-species communities [1]. We hypothesize that 
CviR is important for increasing competitiveness by inducing genes important for competition-
associated behaviors. Further, we hypothesize that when CviR is bound to a noncognate signal, it 
will have a lower binding affinity for the lux box and only genes with high affinity lux boxes will 
be transcribed. Only certain nucleotides in the lux box are strictly conserved while the others can 
vary. Previous experiments in C. violaceum ATCC 12472 demonstrate that single nucleotide 
changes in the lux box can cause an increase or decrease in the binding affinity of CviR for the 
lux box [5]. To test our hypotheses, we investigated the importance of signal promiscuity (the 
ability of CviR to bind multiple AHLs) on survival during competition with Burkholderia 
thailandensis by adding the cognate signal, N-hexanoyl-L-homoserine lactone (C6-HSL), and the 
signals produced by B. thailandensis: C8-HSL, 3OH-C8-HSL, and N-3-hydroxydecanoyl-L-
homoserine lactone (3OH-C10-HSL). We also carried out RNA-sequencing to identify the genes 
that respond to C6-HSL, C8-HSL, N-decanoyl-L-homoserine lactone (C10-HSL), and N-butyryl-
L-homoserine lactone (C4-HSL). 
Materials and Methods 
Bacterial strains and growth conditions. Bacterial strains are listed in Table 1. 
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 Chromobacterium sp. CV017 strains are derivatives of strain ATCC31532 [7]. 
Chromobacterium sp. CV017 (referred to as wild type) has a transposon insertion in gene 
CV_RS05185 causing overexpression of violacein [8, 9]. For the RNA sequencing, we used 
strain CV026, a derivative of CV017, with a second transposon insertion in the cviI gene so that 
it will not produce any AHLs but will respond to exogenous signals (McClean et al 1997).  
  In the co-culture signal addback experiments, Chromobacterium sp. CV017 cviI and cviR 
knockout mutants were constructed using homologous recombination as previously described [1] 
with synthetic gene fragments (IDT) cloned into the pEXG2Gm-derived delivery plasmid. The 
B. thailandensis strain, derived from strain E264, was deficient in bactobolin and all three signal 
synthases: BtaI, BtaII, and BtaIII [1]. To test the responsiveness of Chromobacterium sp. CV017 
to AHLs from B. thailandensis, we added C8-HSL, 3OH-C8-HSL, and 3OH-C10-HSL to the 
growth media. The synthetic AHLs were purchased from Cayman Chemical and dissolved in 
acidified ethyl acetate with glacial acetic acid (0.1 ml L-1). The dissolved AHL was added to a 
250mL Erylmyer flask and dried under N2 gas. The cultures were grown in 20mL Luria-Bertani 
broth containing 50mM morpholnepropanesulfonic acid (MOPS). All co-cultures were grown at 
30°C with shaking at 250rpm.  
 For quantification of AHL production by Chromobacterium sp. CV017, we grew a starter 
culture of Chromobacterium sp. CV017 in 15mm test tubes in 4mL of LB with 50mM MOPS to 
4 OD600. The flasks containing 20mL or 10mL of LB with 50mM MOPS were inoculated at 0.05 
OD600 and incubated until they reached 2 OD600 or 4 OD600. 
Measurement of AHL in Chromobacterium sp. CV017 cultures. The cells were pelleted at 
3000rpm for 20min with no break. The supernatant was removed and 0.4 nmol of D3-C6-HSL 
purchased from Cayman Chemical was added to the cultures as an internal control for 
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quantification. The supernatant was then filter sterilized using a 0.2μM filter. The cultures were 
treated with an equal volume of acidified ethyl acetate. This mixture was shaken vigorously three 
times, allowing the layers to separate between each agitation. The top, aqueous layer was 
removed. The extraction procedure was carried out two more times on the remaining organic 
layer. The combined ethyl acetate fractions were dried under nitrogen gas and resuspended in 
1mL of acidified ethyl acetate. The samples were stored at -20°C. 
 The initial purification of AHL molecules was performed by solid-phase extraction. The 
Sep Pak Plus silica cartridges were activated by 3 successive washings of 6mL of equal volumes 
isooctane and ethyl ether, 6mL of acidified ethyl acetate, and 6mL of equal volume isooctane 
and ethyl ether. The sample was then loaded into the SPE cartridge. The cartridge was washed 
twice with 6mL of isooctane-ether and then eluted with 6mL of acidified ethyl acetate. The 
purified samples were dried and resuspended in 100μl of 1% formic acid acetonitrile and then 
loaded into the time-of-flight (TOF) MS/MS. 
RNA isolation and RNA-seq library construction. All cultures of CV026 were grown in 10mL of 
LB+MOPS in 125mL baffled flasks at 30°C, 230rpm. CV026 was treated with 2μM of C6-HSL 
and 2mL of cells were collected at exponential phase (2.0 OD600) and the transition to stationary 
phase (4.0 OD600). CV026 was also treated with 10μM of C6-HSL, C8-HSL, or C4-HSL and 2mL 
of cell were collected at 4.0 OD600. Two replicates of each treatment were collected. Table 2 
contains a summary of each sample collected for RNA extraction. The cells were treated with 
Qiagen RNAprotect (catalog number 76527) following the manufacturer’s protocol and frozen at 
-80⁰C until mRNA was isolated following the protocol for Qiagen RNeasy Mini Kit (catalog 
number 74104). To enrich for mRNA, we used the MicrobExpress Bacterial mRNA Enrichment 
Kit from Invitrogen (catalog number AM1905) following the manufacture’s protocol. 
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RNA-sequencing libraries were generated by 
the Genome Sequencing Core at the University of 
Kansas and sequencing of the single-read, 50bp 
fragments was performed on the Illumina HiSeq 2500 
platform. The reads were analyzed by the K-INBRE 
Bioinformatics Core at the University of Kanas. Gene 
transcript abundance from each AHL treatment was 
compared to untreated CV026 cells to determine 
AHL responsive genes. We used the DESeq package 
with a false discovery rate (FDR) of 0.05 and only 
evaluated genes showing a 2-fold or greater change in 
transcript abundance in relation to the control CV026 
group [10]. 
Results 
Identifying the AHLs produced by CviI signal 
synthase 
We first quantified AHLs produced by 
Chromobacterium sp. CV017 cultures to determine 
the concentration of AHLs to use in our experiments. To quantify the type and amount of AHL 
produced by Chromobacterium sp. CV017, we grew 20mL of culture to an OD600 4.0. The 
culture was treated with acidified ethyl acetate in order to lysis the cells and separate the AHLs 
from the cell material. After separating the acidified ethyl acetate layer from the cell culture, we 
added deuterated C6-HSL (D3-C6-HSL) as an internal control to measure the amount of signal 
To determine which genes respond to 
AHLs, we grew Chromobacterium sp. 
CV026 in the presence of the indicated 
amount (2μM or 10μM) of each signal 
(C6-HSL, C8-HSL, or C4-HSL). 
Cultures were grown to exponential 
phase (~2 OD600) or transition to 
stationary phase (~4 OD600. As a 
control, we grew CV026 without any 
AHL. Two replicates of each condition 
were collected. 




lost during further purification steps. After reverse phase SPE the sample was run through TOF 
MS/MS. As a control we ran D3-C6-HSL (Figure 1) and C6-HSL (Figure 2) separately to make 
sure our mass/charge (m/z) values correspond with previously published results.  
Figure 1 TOF MS/MS results for D3-C6-HSL  
 
2μM of D3-C6-HSL was suspended in 30% formic acid and 70% acetonitrile and 5ul was 
loaded into the TOF MS/MS. The peak at 203.1 m/z corresponds to the full length D3-C6-HSL 




Figure 2. TOF MS/MS results for C6-HSL 
 
45nM of C6-HSL was suspended in 30% formic acid and 70% acetonitrile and 5ul was loaded 
into the TOF MS/MS. The peak at 200.1 m/z corresponds to full length C6-HSL, the peak at 
102.09 m/z corresponds to the lactone, and the peak at 99.12 m/z corresponds to the acyl side 
chain. 
We then ran our purified supernatant containing the D3-C6-HSL as an internal control. 
Figure 3 is a representation of the results from the 2.0 OD sample. We determined that 
Chromobacterium sp. CV017 produces around 300nM of C6-HSL based on calculation of 




 Figure 3 TOF MS/MS results for purified supernatant 
 
Purified supernatant from 2.0 OD600 cells was resuspended in 1% formic acid acetonitrile and 
loaded into the TOF MS/MS. The peak at 200.1 m/z corresponds to full length C6-HSL, the 
peak at 102.09 m/z corresponds to the lactone, and the peak at 99.12 m/z corresponds to the 


















2μM D3C6-HSL  653    
2.0 OD 10mL 6560 10 1/100 100 
2.0 OD 20mL 28600 43.8 1/200 219 
4.0 OD 10mL 30900 47.3 1/200 237 
4.0 OD 20mL 22000 33.7 1/100 337 
 
Chromobacterium sp. CV017 was grown in either 10mL or 20mL volumes to an optical density 
(OD) of 2.0 or 4.0. The supernatant was extracted and 100μl of each sample was run on TOF 
MS/MS. AHL concentration was calculated by determining the number of counts at the 102 
m/z (lactone moiety) peak for each sample. Based on the number of counts for the internal 
standard (2μM D3C6-HSL), we could determine the amount of AHL in each sample.  
   
There were very few peaks that did not correspond to either C6-HSL (200.3 m/z), the 
lactone (102.09 m/z) or the acyl side chain (99.12 m/z). The peaks that did appear did not match 
any m/z values of known AHLs [3]. In many Proteobacteria the signal synthase will attach an 
acyl side chain of the wrong length 20%-40% of the time. However, CviI produces C6-HSL 90% 
Table 3. Calculating AHL concentration from TOF MS/MS results 
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of the time. The amount of signal produced, 300nM, also corresponds with what is seen in other 
Proteobacteria [3, 11]  
The addition of noncognate AHLs to co-cultures of C. violaceum and B. thailandensis 
 Previous results by Chandler et al. demonstrated that at least one of the AHLs from B. 
thailandensis supernatant activates CviR to promote survival of Chromobacterium sp. CV017 
during competition [1]. We were interested in determining which of the three AHLs (C8-HSL, 
3OH-C8-HSL, 3OH-C10-HSL) produced by B. thailandensis was most effective at inducing QS 
in Chromobacterium sp. CV017. We generated a CviI knockout in CV017 (CviI-) which cannot 
produce AHLs but still has an intact AHL receptor, CviR, to respond to exogenously added 
AHLs. Since Chromobacterium sp. CV017 is severely inhibited by bactobolin produced by B. 
thailandensis, we used a bactobolin knockout strain that was also missing all three LuxI-
homologs. This way the only AHLs present in the co-culture were those that we added to the 
tube.  
We added C6-HSL which is produced by Chromobacterium sp. CV017 as a control to 
demonstrate that the addition of cognate signal increased competitiveness. We then added each 
of the signals produced by B. thailandensis, C8-HSL, 3OH-C8-HSL, and C10-HSL at 250nM, 
500nM, and 1μM (Figure 3). At all concentrations, C6-HSL was able to increase competitiveness 
compared to the no signal control (Mann Whitney, p-value < 0.016). We also observed increased 
Chromobacterium sp. CV026 survival as the signal concentration increased. At 1μM, all signals 
except 3OH-C10-HSL were able to increase survival compared to no signal control (Mann 
Whitney, p-value = 0.008). At 250nM only C6-HSL was able to significantly increase survival 
(Mann Whitney, p-value = 0.016) while C8-HSL was approaching a significance compared to no 
signal control (Mann Whitney, p-value = 0.056). We created a CviR knockout in CV017 (CviR-) 
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and used this strain in competitions with B. thailandensis and 1μM of each signal. We saw no 
increase in CviR- survival demonstrating that the increase in survival is dependent on CviR.  
  
AHL-regulated genes 
Our competition experiments suggested that CviR can respond to C8-HSL and activate 
expression of genes important for competition. To determine the regulon of genes controlled by 
C8-HSL-bound CviR, we used an RNA-seq transcriptomic approach. We used Chromobacterium 
sp. CV026 which has a transposon in the AHL synthase, CviI. This strain allowed us to measure 
the effect of each noncognate AHL without interference by the cognate signal, C6-HSL. CV026 
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still has a wildtype AHL receptor, CviR, so it will respond to exogenously added AHLs. First, 
we needed to determine the genes induced by the cognate signal compared to no AHL exposure. 
We compared transcripts from the exogenously added C6-HSL cultures, at logarithmic growth 
phase (2 OD600) and the transition from logarithmic to stationary phase (4 OD600). Previous 
research has shown that some QS-controlled genes also require other cellular signals and may 
only be transcribed as the cell enters stationary phase [12]. Finally, to address which genes are 
responsive to noncognate AHLS, we exogenously added C8-HSL and C4-HSL to CV026 and 
collected the mRNA at 4 OD600.  
We harvested RNA after treatment with 2μM (C6-HSL and C8-HSL) and 10μM signal 
(C6-HSL, C8-HSL, and C4-HSL) based on the amount of signal needed to activate production of 
violacein (causing cell cultures to turn visibly purple) at the same time as Chromobacterium sp. 
CV017. We sequenced the RNA libraries from two biological replicates for each signal 
concentration and optical density. Overall, we saw more activation than repression of genes 
(Figure 4A). Only 2μM C6-HSL was tested at exponential and at the transition to stationary 
phase. During exponential growth, there were 244 genes that responded to 2μM of C6-HSL with 
most of the genes being repressed (Figure 4A). However, during the transition to stationary 





All the noncognate signals were tested at the transition to stationary phase (4OD). The cognate 
signal C6-HSL causes the largest change in gene transcription followed by C8-HSL, and C4-HSL 
We determined AHL responsive genes based on a false discovery rate (FDR) 0.05 and 
compared to a no AHL control. A) The number of genes up- or down-regulated at least 1 
log2 for each sample. B) Histogram of all up-regulated genes for 10μM C6-HSL, 10μM C8-
HSL, and 10μM C4-HSL. There is a higher frequency of 2-3-fold activated genes in 




has the smallest effect on gene transcription (Figure 4A). However, when we look at the 
histogram of all up-regulated genes, there is a shift in the distribution of the degree of activation 
(Figure 4B). While C6-HSL has the widest range in log2 fold-change, most genes are up-
regulated 1- to 2-fold. However, both noncognate 
signals have less genes up-regulated 1-fold 
compared to C6-HSL. The majority of non-cognate 
responsive genes are upregulated 1.5- to 3-fold. 
This lends support to our hypothesis that only 
genes with high affinity lux box sequences will 
respond to noncognate AHLs. 
When we compare each noncognate signal 
to the cognate signal, we see that most noncognate 
genes are also responsive to C6-HSL (Figure 5). 
There is a core set of 123 genes that respond to all 
3 AHLs. However, there are only six genes that 
respond to C8-HSL and C4-HSL: glutathione S-transferase and five hypothetical proteins. 
Our hypothesis states that ‘eavesdropping’ will increase the competitiveness of 
Chromobacterium sp. CV017 by inducing genes important for competition-associated behaviors. 
To evaluate our hypothesis, we looked at the top and bottom 20% of differentially expressed 
genes for each signal (Table 4 and 5). Nearly all the genes in the top 20% are associated with 
competition: iron scavenging (2Fe-2S binding protein and SbnAB) [13, 14]; antimicrobials (non-
ribosomal peptide and violacein); and chemotaxis [15, 16]. In the bottom 20% of differentially 
expressed genes most genes are associated with metabolism. However, there are a few genes that 
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are associated with competition including cdeA (RND transporter) from Chapter III and a 
polyketide cyclase. 
While noncognate AHLs activate a smaller portion of genes than C6-HSL, the majority of 
noncognate AHLs responsive genes have a higher log2 fold-change than C6-HSL responsive 
genes. This may be because the 1-fold differentially expressed genes having lux boxes with low 
affinity for CviR. Since noncognate AHLs cause a decrease in the affinity of CviR for DNA, 
these genes may not be expressed or expressed at very low levels. Additionally, the majority of 
genes that are highly responsive to noncognate AHLs are associated with competition supporting 





Table 4. Top 20% of differentially expressed genes for each AHL 
 
The differentially expressed genes were sorted by log2 fold-change. The top 20% of genes for each 
signal (50 genes for C6-HSL, 38 genes for C8-HSL, 34 genes for C4-HSL) are displayed after the 




Table 5. Bottom 20% of differentially expressed genes for each AHL 
 
The differentially expressed genes were sorted by log2 fold-change. The bottom 20% of genes for 
each signal (50 genes for C6-HSL, 38 genes for C8-HSL, 34 genes for C4-HSL) are displayed after 
the hypothetical genes were removed. There are fewer genes associated with competition and less 





The ability of C. violaceum strains ATCC 12472 and ATCC 31531 (parent strain of 
CV017) to respond to various AHLs produced by other bacteria has been widely reported [4, 17, 
18]. However, few studies have addressed the potential advantages of C. violaceum response to 
noncognate AHLs, and how this relates to gene control in the cell. Only one publication 
examined the type of AHLs produced by C. violaceum ATCC 12472 by placing the luxI-
homolog, cviI, in Escherichia coli and conducting mass spectrometry on filtered supernatant 
[17]. They reported that the major signal is 3OH-C10-HSL with two other major products. While 
their m/z results (294) do match their control, it does not match other published results for 
known AHLs [3]. Additionally, they do not identify the other peaks observed in their mass 
spectrometry. Since their m/z results do not match other published results, we are unable to 
ascertain any other AHLs that may be produced by C. violaceum ATCC 12472. We show for the 
first time through TOF MS/MS of Chromobacterium sp. CV017 supernatant that the signal 
synthase, CviI, produces almost exclusively C6-HSL. Over 90% of all peaks correspond with C6-
HSL and the remaining peaks do not correspond with any known AHL m/z profiles. This 
supports our hypothesis that Chromobacterium sp. CV017 ‘eavesdrops’ on other AHLs because 
it gains a benefit during competition and not because CviI produces a broad-range of AHLs. 
Previous research, together with our results, support the idea that Chromobacterium sp. 
CV017 detects C8-HSL and 3OH-C8-HSL during competition with B. thailandensis which results 
in increased survival of Chromobacterium sp. CV017. We were surprised to learn that 
Chromobacterium sp. CV017 also responds to 3OH-C8-HSL since previous publication reported 
that Chromobacterium sp. CV026 did not respond to AHLs with substitutions on the 3rd carbon 
[4, 19]. However, 3OH-C10-HSL which also had a substitution of the 3
rd carbon had no effect 
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during competition. This may be because C10-HSL already has a low binding affinity for the 
receptor based on violacein expression making modifications on the 3rd carbon even more 
detrimental [4, 19].  
Our RNA transcriptomics provides the first look through mRNA sequencings at AHL 
responsive genes and provides some clues as to the benefits of Chromobacterium sp. CV017 
response to noncognate AHLs. Of the noncognate signals tested, C8-HSL most closely mimicked 
C6-HSL by inducing 20.6% of C6-HSL responsive genes at 2μM and 64.8% of C6-HSL 
responsive genes at 10μM. This mimicry corresponds with what has been observed in the ability 
C8-HSL to induce violacein expression in the biosensor strain CV026 [20]. Additionally, the 
crystal structures generated by Bassler et al. demonstrate that C8-HSL has the smallest change to 
the protein conformation compared to C6-HSL indicating that CviR is most likely exhibiting 
wild-type behavior [20]  
Our hypothesis that noncognate AHLs will have the greatest control over competition 
factors was addressed by determining the genes that responded 10μm of C6-HSL, C8-HSL, or C4-
HSL. The majority of genes up-regulated only by C8-HSL or C4-HSL have no known function. 
However, when we evaluated the predicted function of the genes up-regulated in all three 
samples, we saw an enrichment in the total percent of competition-associated factors, such as: 
antimicrobial agents, antibiotic resistance efflux pumps, T3SS, chemotaxis proteins, and 
proteases. This group of genes was the only group that increased in response to noncognate 
AHLs lending support to our hypothesis that ‘eavesdropping’ is important during competition. 
While we have not been able to definitively answer our hypothesis, we believe we have 
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Chromobacterium sp. CV017 reveals a need for phylogenetic comparisons during genome 
sequencing  
Historically, bacteria were identified by physical and metabolic characteristics. These 
traits, while useful in identifying and characterizing bacteria, have also lead to the improper 
classification of bacterial species. We believe this occurred when the parent strain, C. violaceum 
ATCC 31532, of our lab strain Chromobacterium sp. CV017 was identified in 1982 [1]. Based 
on the phylogenetic analysis of the 16S RNA, there are other Chromobacterium species that 
appear to be misidentified based on their groupings.  
The misidentification of bacterial strains is not a new problem. The taxonomic schemes 
used for identifying and classifying bacteria need to be dependable, reproducible, and instructive. 
Historically, this means scientists focused on identifying bacterial species by phenotypes, such 
as: Gram staining, metabolism of compounds as energy sources, secretion of enzymes, 
production of toxins, and growth at various pH, temperatures, and salt concentrations [2]. 
However, phenotype-based taxonomy in the first half of the 1900s lead to a large multiplication 
of species because not enough features were used for new taxa description. The introduction of 
DNA-DNA hybridization in the 1970s allowed DNA homologs and molecular fingerprinting 
techniques (rep-PCR, amplified fragment length polymorphism [AFLP], and pulse-field gel 
electrophoresis [PFGE]) to be used in conjunction with physiological descriptions [3]. These 
methods lead to the publication of the Approved Lists of Bacterial Names that consolidation of 
90% of all species described in the 1957 Bergey’s Manual. 
The introduction of 16S rRNA gene sequencing brought about a new system for 
identifying bacterial species. Current species delineation is defined as a group of strains that have 
greater than 70% DNA-DNA hybridization similarity, less than 5°C change in DNA melting 
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temperature (Tm), less than 5% difference in %GC, and greater than 98% similarity in 16S 
rRNA [3]. Next-generation sequencing (NGS) is changing this system again. The price of 
investing in and maintaining NGS systems continues to decrease making whole genome 
sequencing (WGS) a viable method for determining speciation [4]. WGS allows more genes to 
be used to delineate species than DNA-DNA hybridization or 16S rRNA sequencing alone [3]. 
WGS should be the standard for identifying new bacterial species. Numerous research has 
already demonstrated that bacterial species can be identified by unique genome characteristics 
[5-8] Indeed, it has been proposed that the description of new taxa should include a draft genome 
sequence with 20 times coverage [3].  
Improper speciation is not limited to Chromobacterium. From 2003-2007, publications 
on the reclassification of bacterial strains doubled from the preceding 5 years (Figure 1). In the 
last 5 years, the number of publications on misidentified bacterial species has increased. The 
number of newly published bacterial genomes has also increased based on genome submissions 
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to the National Center of Biotechnology Information (NCBI) genomes database. These numbers 
will continue to increase as genome sequencing becomes cheaper and more automated. New 
guidelines that require phylogenetic comparisons are needed to ensure newly sequenced 
genomes from bacteria that have already been named are evaluated for misclassification. The 
addition of a 16S or other phylogenetic comparison step in sequencing or annotation pipelines 
may alert researchers to the possibility that their bacterial strain has been misidentified. This 
check would allow researchers to publish genome announcements with recommendations for the 
proper nomenclature of the bacteria. 
Competition provides selective advantage for quorum sensing systems  
One of the leading questions in the quorum sensing (QS) field is how QS is maintained in 
the population when QS-deficient cheaters can be isolated from the environment, infections, and 
laboratory models. QS-deficient cheaters have a growth advantage over cooperating bacteria, but 
cheaters rarely reach a high enough frequency in the population to cause a collapse of the 
population. There have been a numerous examples of cheater restraint in populations through kin 
selection, spatial structuring (biofilm), and privatization of public goods [9]. While the coupling 
of public and private goods has been demonstrated to restrain cheaters, we provide the first 
evidence that QS-control of antibiotic efflux pumps can provide a sufficient benefit to 
cooperators. However, this mechanism of cheater restraint would only work if bacteria are 
frequently in competition with other organisms. Indeed, this may be the case as recent research 
indicates that competition and not cooperation dominates the interactions between microbial 
species [10].  
 It is possible that even within one species there are multiple mechanisms for maintaining 
QS systems. During the casein evolution experiments, we found that AHL receptor mutations 
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were not the only mutants to arise in the population. We observed within each culture without 
antibiotic treatment subpopulation of mutants with reduced violacein expression. These mutants 
still had intact QS genes, cviI and cviR, and produced protease but produced extremely low 
levels of violacein. Chromobacterium sp. CV017 has a transposon in the violacein repressor, 
VioS. This gene should be sequenced to determine if growth on casein is enough of a stress to 
cause a loss of this transposon and reactivation of VioS. Additionally, the ability of cheaters to 
emerge from these mutants during casein evolution should be tested. VioS has been shown to 
regulate protease and chitinolytic activity [11]. These mutants may experience less of metabolic 
cost from QS making it less advantageous to cheat and could be another method for limiting the 
burden of cheaters. 
QS-regulon in Chromobacterium sp. CV026 reveals secondary metabolite clusters and hydrogen 
cyanide resistance  
 One of the problems with using Chromobacterium sp. CV017 in our competition 
experiments is that we do not know what antimicrobial factor is responsible for inhibiting 
Burkholderia thailandensis growth. Through the RNA-sequencing, we have identified the genes 
for a non-ribosomal peptide synthase, a polyketide synthase cluster, and hydrogen cyanide.  
Future work will focus on characterizing the importance of each of these genes in our dual-
species competition model. Because the filtered supernatant of Chromobacterium sp. CV017 is 
not very good at inhibiting growth of B. thailandensis, we hypothesis that the antimicrobial agent 
is hydrogen cyanide. 
 We were also able to identify the genes that provide immunity to hydrogen cyanide based 
on studies in Pseudomonas aeruginosa and Chromobacterium piscinae [12]. In 
Chromobacterium sp. CV017 these genes are Cv017_17020, Cv017_17025, and Cv017_17030 
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which encode for cytochrome O ubiquinol oxidase I, II, and III, respectively. Interestingly these 
genes were only upregulated in cells at 4 OD600 treated with 2μM C6-HSL. In all other treatments 
the genes were either down-regulated compared to no signal control or absent in the case of 
10μM C4-HSL. It is possible that there are multiple transcription factors for these hydrogen 
cyanide resistance genes. Future work should focus on deleting each gene separately and in-
tandem in order to determine their importance for resistance in both the QS and QS-deficient 
background. 
‘Eavesdropping’ in Chromobacterium sp. CV017 may provide an advantage during competition 
under select circumstances 
 In Chapter IV we demonstrate that Chromobacterium sp. CV017 can detect physiological 
levels of C8-HSL and 3OH-C8-HSL produced by B. thailandensis. Previous in silico modeling 
indicates that Chromobacterium sp. CV017 will only benefit from detecting AHLs from B. 
thailandensis when the QS threshold is high for both species [13]. This allows for the early 
activation of QS-controlled antibiotics and the antibiotic resistance efflux pump, cdeAB-oprM 
and increases survival of Chromobacterium sp. CV017.  
However, our experiments assume that there is no competition between cognate and 
noncognate AHLs. If CviR can only form a homodimer with another subunit bound to the same 
signal, then there is the potential for competition between CviR:AHL homodimers. Indeed, 
experiments using a vioA-gfp reporter plasmid in Escherichia coli indicate that when the cognate 
AHL (C6-HSL) is present, then C8-HSL and C10-HSL act as partial antagonists and decrease GFP 
expression [14]. To address this question, we should repeat our co-culture competition 
experiments with wild type Chromobacterium sp. CV017. Additionally, we should repeat our 
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transcriptomics experiments with both cognate and noncognate AHLs present during growth to 
determine if there is a change in the QS-regulon. 
This dissertation provides evidence that Chromobacterium species can be classified based 
on WGS and unique genome characteristics instead of time-intensive physiological 
characteristics. There is a strong need for phylogenetic analysis when sequence any genome 
regardless of if it is a recent isolate. We also demonstrate QS-controlled antibiotic efflux pumps 
can restrain QS-deficient cheaters when antibiotics are produced during competition with other 
species. While this co-regulation of antibiotic production and antibiotic resistance has only been 
observed in a handful of species (P. aeruginosa and E. coli), there are probably many more soil 
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